data_5ieb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ieb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 89' ' ' SER . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 87' ' ' ASP . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.4 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.465 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.467 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.421 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt . . . . . 0 C--O 1.229 -0.011 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.467 ' HB2' ' HZ1' ' A' ' 111' ' ' LYS . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 50' ' ' ILE . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 90' ' ' VAL . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 88' ' ' ASP . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.463 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.505 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.459 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.459 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.717 0.294 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 90' ' ' VAL . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 88' ' ' ASP . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 89' ' ' SER . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 87' ' ' ASP . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.336 0.112 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -68.23 164.07 21.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.422 0.289 . . . . 0.0 110.927 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 4.56 10.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.69 0.396 . . . . 0.0 111.601 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -151.68 99.28 2.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt -68.01 -14.38 62.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.34 -0.12 14.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.239 -169.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 tpp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -66.92 157.85 32.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 110.934 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 -2.0 30.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.865 0.466 . . . . 0.0 111.29 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp -153.72 104.71 2.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.461 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.58 -9.76 57.63 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.14 -7.93 31.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.93 0.332 . . . . 0.0 111.464 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.253 1.261 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.908 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.338 0.113 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 t -68.02 149.54 49.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.311 0.245 . . . . 0.0 110.437 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.58 2.51 36.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.618 0.367 . . . . 0.0 111.714 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.37 105.88 3.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 89' ' ' SER . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 87' ' ' ASP . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.86 -15.47 62.95 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.17 -12.63 43.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.922 0.328 . . . . 0.0 111.19 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.914 -1.517 . . . . 0.0 112.673 -178.075 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.5 p -154.21 179.63 8.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.879 0.471 . . . . 0.0 109.88 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.03 5.98 4.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.897 0.479 . . . . 0.0 111.951 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.22 94.54 2.15 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.409 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.97 -17.3 61.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.4 mp -114.4 -16.22 11.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.52 0.328 . . . . 0.0 111.5 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.364 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.404 0.145 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -72.3 -6.76 45.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.794 0.437 . . . . 0.0 111.332 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.97 1.15 16.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.814 0.446 . . . . 0.0 111.56 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp -150.45 98.93 2.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.738 0.415 . . . . 0.0 110.09 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.68 -25.58 56.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -89.44 -2.71 58.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.697 0.399 . . . . 0.0 111.7 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.337 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 ttp . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 t -65.25 157.79 27.98 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.477 0.311 . . . . 0.0 110.75 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.2 -0.53 14.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.378 0.271 . . . . 0.0 111.213 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.13 128.66 9.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.465 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -14.03 45.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.18 -0.99 57.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.103 0.561 . . . . 0.0 110.466 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.277 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.444 0.164 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -69.28 157.75 36.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.521 0.328 . . . . 0.0 110.468 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.55 3.39 13.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.592 0.357 . . . . 0.0 111.551 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.16 103.53 3.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.406 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.467 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.79 -14.1 59.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.6 -14.87 10.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.776 0.43 . . . . 0.0 111.423 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.301 -178.198 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 47.59 34.27 3.48 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 112.393 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.32 12.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.854 0.462 . . . . 0.0 111.538 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt -66.23 147.36 53.44 Favored 'General case' 0 C--N 1.336 -0.016 0 C-N-CA 123.418 0.687 . . . . 0.0 109.723 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.467 ' HB2' ' HZ1' ' A' ' 111' ' ' LYS . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.72 -17.44 64.56 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -113.91 -36.77 4.69 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.767 0.427 . . . . 0.0 109.876 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.252 1.211 0 CA-C-O 116.993 -1.479 . . . . 0.0 110.255 -176.255 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -155.93 158.16 37.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.454 0.301 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.94 18.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.777 0.431 . . . . 0.0 111.178 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp -148.17 107.48 3.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.416 ' H ' HG12 ' A' ' 50' ' ' ILE . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp -77.44 -26.42 51.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.39 -11.79 14.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.684 0.394 . . . . 0.0 111.244 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.188 -177.623 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 t -155.29 157.08 36.65 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.513 0.325 . . . . 0.0 110.3 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.87 1.36 31.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.698 0.399 . . . . 0.0 111.116 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp -151.87 109.07 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 90' ' ' VAL . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 88' ' ' ASP . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.463 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.45 -5.15 17.67 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.04 -37.28 1.29 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.954 0.502 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.909 -178.36 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.35 155.47 33.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.663 0.385 . . . . 0.0 110.294 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.1 4.6 19.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.845 0.458 . . . . 0.0 111.157 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -148.0 101.24 3.27 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.42 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.42 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.3 -13.28 48.94 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -92.48 0.5 57.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.696 0.399 . . . . 0.0 110.615 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.839 -1.553 . . . . 0.0 112.982 -177.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -70.42 151.82 44.75 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.611 0.364 . . . . 0.0 111.026 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.65 4.09 17.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.582 0.353 . . . . 0.0 111.551 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp -149.42 103.17 3.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.447 0.299 . . . . 0.0 110.264 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.475 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp -75.97 -25.06 55.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.13 -0.01 57.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.482 0.313 . . . . 0.0 111.701 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.81 -1.09 . . . . 0.0 112.348 -179.154 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.113 ' N ' ' H2 ' ' A' ' 1' ' ' MET . 60.4 tpp . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.516 0.198 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -77.82 -7.45 56.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.719 0.408 . . . . 0.0 111.725 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.81 9.4 3.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.701 0.4 . . . . 0.0 111.447 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp -149.46 117.36 6.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.829 0.452 . . . . 0.0 109.818 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.2 -11.9 52.66 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.86 3.83 49.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.648 0.379 . . . . 0.0 110.843 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.001 -1.476 . . . . 0.0 113.037 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -65.86 151.45 46.66 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.605 0.362 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.93 -0.58 31.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.628 0.371 . . . . 0.0 111.584 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.94 115.78 4.55 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.413 0.285 . . . . 0.0 110.337 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.505 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.58 -23.92 58.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.65 -3.51 58.21 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.595 0.358 . . . . 0.0 111.642 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.458 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -155.69 157.53 36.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.825 0.45 . . . . 0.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.96 8.13 21.64 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.843 0.457 . . . . 0.0 111.213 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.27 78.53 1.66 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.179 0.591 . . . . 0.0 109.695 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.469 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.83 -10.72 60.13 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.55 -7.51 37.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.568 0.347 . . . . 0.0 111.421 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.064 -1.446 . . . . 0.0 112.296 -178.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.216 0.055 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -73.9 172.28 11.88 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.906 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.89 16.17 0.57 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.164 0.586 . . . . 0.0 111.651 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.45 106.77 7.66 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.412 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp -73.51 -25.5 60.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -88.26 -4.49 58.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.438 0.295 . . . . 0.0 111.427 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.38 -178.613 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -68.5 164.07 22.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.619 0.368 . . . . 0.0 110.835 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 4.1 7.99 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.571 0.348 . . . . 0.0 111.864 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.47 107.24 3.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.459 ' HA ' ' HE2' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt -64.78 -23.59 67.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.8 -36.66 5.85 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 110.02 178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.8 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.186 -1.387 . . . . 0.0 110.482 -175.342 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mtp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t 61.0 164.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.926 0.89 . . . . 0.0 112.252 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.03 2.04 47.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.069 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -156.49 123.55 5.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.714 0.406 . . . . 0.0 110.17 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.459 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.36 -23.53 61.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.46 -4.85 57.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.471 0.308 . . . . 0.0 111.547 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.386 -1.292 . . . . 0.0 112.223 -178.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -74.43 171.53 13.57 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.545 0.338 . . . . 0.0 110.717 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.4 5.72 8.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.865 0.466 . . . . 0.0 111.919 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp -150.96 98.01 2.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.938 0.335 . . . . 0.0 110.754 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 90' ' ' VAL . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' H ' ' C ' ' A' ' 88' ' ' ASP . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.412 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE1' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.18 -10.47 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.44 -7.16 32.3 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.866 0.303 . . . . 0.0 111.376 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.772 -1.108 . . . . 0.0 112.547 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p 48.04 31.69 2.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 112.169 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.5 6.2 9.12 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.546 0.339 . . . . 0.0 111.52 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.45 125.12 24.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.054 0.542 . . . . 0.0 110.189 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 89' ' ' SER . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 87' ' ' ASP . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.23 -11.28 59.06 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.26 -8.51 32.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.814 0.279 . . . . 0.0 111.538 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.981 -1.485 . . . . 0.0 112.568 -178.07 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' ARG . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt . . . . . 0 C--O 1.229 -0.011 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 50' ' ' ILE . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 32' ' ' VAL . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 72' ' ' LEU . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.48 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.499 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.546 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' C ' ' A' ' 65' ' ' SER . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 4' ' ' LEU . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 15' ' ' LEU . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.408 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.717 0.294 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 72' ' ' LEU . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.336 0.112 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -68.23 164.07 21.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.422 0.289 . . . . 0.0 110.927 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 4.56 10.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.69 0.396 . . . . 0.0 111.601 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -151.68 99.28 2.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' ARG . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt -68.01 -14.38 62.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.3 mm? -113.34 -0.12 14.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.239 -169.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 tpp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -66.92 157.85 32.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 110.934 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 -2.0 30.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.865 0.466 . . . . 0.0 111.29 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp -153.72 104.71 2.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.58 -9.76 57.63 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.14 -7.93 31.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.93 0.332 . . . . 0.0 111.464 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.253 1.261 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.908 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.338 0.113 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 t -68.02 149.54 49.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.311 0.245 . . . . 0.0 110.437 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.58 2.51 36.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.618 0.367 . . . . 0.0 111.714 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.37 105.88 3.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.86 -15.47 62.95 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.17 -12.63 43.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.922 0.328 . . . . 0.0 111.19 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.914 -1.517 . . . . 0.0 112.673 -178.075 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.5 p -154.21 179.63 8.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.879 0.471 . . . . 0.0 109.88 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.03 5.98 4.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.897 0.479 . . . . 0.0 111.951 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.22 94.54 2.15 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.97 -17.3 61.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.4 mp -114.4 -16.22 11.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.52 0.328 . . . . 0.0 111.5 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.364 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.404 0.145 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -72.3 -6.76 45.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.794 0.437 . . . . 0.0 111.332 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.97 1.15 16.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.814 0.446 . . . . 0.0 111.56 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp -150.45 98.93 2.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.738 0.415 . . . . 0.0 110.09 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.68 -25.58 56.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -89.44 -2.71 58.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.697 0.399 . . . . 0.0 111.7 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.337 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 ttp . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 t -65.25 157.79 27.98 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.477 0.311 . . . . 0.0 110.75 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.2 -0.53 14.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.378 0.271 . . . . 0.0 111.213 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.13 128.66 9.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -14.03 45.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.8 mm? -91.18 -0.99 57.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.103 0.561 . . . . 0.0 110.466 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.277 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.444 0.164 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -69.28 157.75 36.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.521 0.328 . . . . 0.0 110.468 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.55 3.39 13.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.592 0.357 . . . . 0.0 111.551 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.16 103.53 3.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.79 -14.1 59.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.6 -14.87 10.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.776 0.43 . . . . 0.0 111.423 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.301 -178.198 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 47.59 34.27 3.48 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 112.393 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.32 12.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.854 0.462 . . . . 0.0 111.538 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt -66.23 147.36 53.44 Favored 'General case' 0 C--N 1.336 -0.016 0 C-N-CA 123.418 0.687 . . . . 0.0 109.723 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.72 -17.44 64.56 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.3 mm? -113.91 -36.77 4.69 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.767 0.427 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.252 1.211 0 CA-C-O 116.993 -1.479 . . . . 0.0 110.255 -176.255 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -155.93 158.16 37.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.454 0.301 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.94 18.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.777 0.431 . . . . 0.0 111.178 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp -148.17 107.48 3.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 50' ' ' ILE . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 32' ' ' VAL . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp -77.44 -26.42 51.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.39 -11.79 14.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.684 0.394 . . . . 0.0 111.244 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.188 -177.623 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 t -155.29 157.08 36.65 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.513 0.325 . . . . 0.0 110.3 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.87 1.36 31.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.698 0.399 . . . . 0.0 111.116 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp -151.87 109.07 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.45 -5.15 17.67 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.04 -37.28 1.29 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.954 0.502 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.909 -178.36 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.35 155.47 33.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.663 0.385 . . . . 0.0 110.294 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.1 4.6 19.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.845 0.458 . . . . 0.0 111.157 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -148.0 101.24 3.27 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 72' ' ' LEU . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.48 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.3 -13.28 48.94 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -92.48 0.5 57.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.696 0.399 . . . . 0.0 110.615 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.839 -1.553 . . . . 0.0 112.982 -177.643 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -70.42 151.82 44.75 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.611 0.364 . . . . 0.0 111.026 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.65 4.09 17.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.582 0.353 . . . . 0.0 111.551 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp -149.42 103.17 3.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.447 0.299 . . . . 0.0 110.264 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.499 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp -75.97 -25.06 55.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.13 -0.01 57.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.482 0.313 . . . . 0.0 111.701 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.81 -1.09 . . . . 0.0 112.348 -179.154 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 tpp . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.516 0.198 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -77.82 -7.45 56.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.719 0.408 . . . . 0.0 111.725 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.81 9.4 3.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.701 0.4 . . . . 0.0 111.447 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp -149.46 117.36 6.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.829 0.452 . . . . 0.0 109.818 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.2 -11.9 52.66 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.86 3.83 49.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.648 0.379 . . . . 0.0 110.843 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.001 -1.476 . . . . 0.0 113.037 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -65.86 151.45 46.66 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.605 0.362 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.93 -0.58 31.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.628 0.371 . . . . 0.0 111.584 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.94 115.78 4.55 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.413 0.285 . . . . 0.0 110.337 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.546 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' C ' ' A' ' 65' ' ' SER . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.58 -23.92 58.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.65 -3.51 58.21 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.595 0.358 . . . . 0.0 111.642 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.458 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -155.69 157.53 36.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.825 0.45 . . . . 0.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.96 8.13 21.64 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.843 0.457 . . . . 0.0 111.213 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.27 78.53 1.66 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.179 0.591 . . . . 0.0 109.695 -177.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 4' ' ' LEU . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 15' ' ' LEU . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.408 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.83 -10.72 60.13 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.55 -7.51 37.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.568 0.347 . . . . 0.0 111.421 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.064 -1.446 . . . . 0.0 112.296 -178.582 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.216 0.055 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -73.9 172.28 11.88 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.906 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.89 16.17 0.57 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.164 0.586 . . . . 0.0 111.651 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.45 106.77 7.66 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp -73.51 -25.5 60.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -88.26 -4.49 58.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.438 0.295 . . . . 0.0 111.427 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.38 -178.613 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -68.5 164.07 22.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.619 0.368 . . . . 0.0 110.835 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 4.1 7.99 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.571 0.348 . . . . 0.0 111.864 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.47 107.24 3.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt -64.78 -23.59 67.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.3 mm? -109.8 -36.66 5.85 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 110.02 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.8 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.186 -1.387 . . . . 0.0 110.482 -175.342 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mtp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t 61.0 164.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.926 0.89 . . . . 0.0 112.252 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.03 2.04 47.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.069 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -156.49 123.55 5.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.714 0.406 . . . . 0.0 110.17 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.36 -23.53 61.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.46 -4.85 57.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.471 0.308 . . . . 0.0 111.547 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.386 -1.292 . . . . 0.0 112.223 -178.699 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -74.43 171.53 13.57 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.545 0.338 . . . . 0.0 110.717 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.4 5.72 8.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.865 0.466 . . . . 0.0 111.919 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp -150.96 98.01 2.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.938 0.335 . . . . 0.0 110.754 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 72' ' ' LEU . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.18 -10.47 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.44 -7.16 32.3 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.866 0.303 . . . . 0.0 111.376 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.772 -1.108 . . . . 0.0 112.547 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p 48.04 31.69 2.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 112.169 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.5 6.2 9.12 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.546 0.339 . . . . 0.0 111.52 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.45 125.12 24.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.054 0.542 . . . . 0.0 110.189 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.23 -11.28 59.06 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.26 -8.51 32.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.814 0.279 . . . . 0.0 111.538 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.981 -1.485 . . . . 0.0 112.568 -178.07 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' ARG . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp . . . . . 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.409 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt . . . . . 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt . . . . . 0 C--O 1.229 -0.011 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 50' ' ' ILE . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 32' ' ' VAL . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 72' ' ' LEU . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.48 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.499 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp . . . . . 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.546 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' C ' ' A' ' 65' ' ' SER . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 4' ' ' LEU . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 15' ' ' LEU . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.408 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp . . . . . 0 N--CA 1.453 -0.304 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.717 0.294 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 72' ' ' LEU . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt . . . . . 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.477 0.878 0 CA-C-O 120.336 0.112 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -68.23 164.07 21.39 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.422 0.289 . . . . 0.0 110.927 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.44 4.56 10.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.69 0.396 . . . . 0.0 111.601 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 23.1 tp -151.68 99.28 2.58 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -141.52 -30.88 0.59 Allowed 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -82.14 107.61 14.96 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 30.2 mt -129.73 134.37 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.109 0 CA-C-O 120.528 0.204 . . . . 0.0 111.227 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 tp -95.91 153.37 17.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.805 0.442 . . . . 0.0 109.948 174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.4 mt -126.57 143.26 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.12 116.06 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -154.34 161.93 41.47 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.689 0.796 . . . . 0.0 110.047 -176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -124.55 -5.29 7.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 82.5 tt0 -94.0 134.24 26.34 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 173.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 33.8 Cg_exo -61.61 -41.17 41.3 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.475 2.117 . . . . 0.0 111.959 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -68.57 -49.05 62.37 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 122.496 0.318 . . . . 0.0 111.432 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.0 mm -68.43 -26.14 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.08 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.31 -45.78 53.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.355 -0.216 . . . . 0.0 110.887 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.2 ptp -75.16 -27.03 59.54 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.2 -0.312 . . . . 0.0 110.914 -177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 91.7 mmm -71.5 -35.0 70.61 Favored 'General case' 0 N--CA 1.458 -0.07 0 O-C-N 122.33 -0.232 . . . . 0.0 110.59 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.89 -32.39 63.57 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.67 -30.91 68.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 117.727 0.239 . . . . 0.0 110.758 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -75.02 -40.55 60.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.183 0.193 . . . . 0.0 110.554 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -69.73 -26.69 64.45 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.2 mt -74.1 -38.68 63.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -68.03 -36.37 79.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.437 -0.165 . . . . 0.0 111.316 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.06 -24.54 15.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.0 mt -84.59 14.68 4.36 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.485 0.314 . . . . 0.0 110.569 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 59.09 24.19 12.47 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -99.15 -174.13 2.67 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -134.83 118.3 13.24 Favored Pre-proline 0 N--CA 1.454 -0.275 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.87 92.66 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.157 2.571 . . . . 0.0 108.629 169.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 m -75.62 -7.31 9.97 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -173.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.14 160.84 16.66 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.335 -0.46 . . . . 0.0 112.032 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -141.71 137.09 31.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.781 0.832 . . . . 0.0 111.449 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -136.46 160.34 37.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -125.48 5.08 7.61 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.1 p -131.27 149.33 52.61 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 123.14 0.576 . . . . 0.0 111.629 173.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.04 -24.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.0 -27.53 63.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.61 -28.65 51.09 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.48 -35.95 60.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 117.143 0.471 . . . . 0.0 110.346 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.2 mt -71.03 -29.76 65.78 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.74 -28.23 55.69 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.021 0.128 . . . . 0.0 110.861 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -82.06 -40.83 21.45 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.1 p -68.56 -28.18 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.072 0 CA-C-N 117.718 0.235 . . . . 0.0 111.463 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -75.0 -18.23 60.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.412 0.285 . . . . 0.0 110.991 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -70.98 -22.94 62.12 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.53 -173.62 36.72 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.78 -1.83 61.28 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.2 mt -86.72 140.77 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 117.572 0.686 . . . . 0.0 109.887 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -94.81 -28.43 15.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.603 0.361 . . . . 0.0 111.315 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.97 170.5 15.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.275 0.63 . . . . 0.0 109.677 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.69 32.47 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.888 -0.508 . . . . 0.0 111.812 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.2 mt -126.71 143.68 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.569 0.748 . . . . 0.0 108.997 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.3 tp -146.73 124.22 11.71 Favored 'General case' 0 C--N 1.339 0.125 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -78.02 155.17 30.85 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.03 -27.66 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 122.422 0.289 . . . . 0.0 111.569 -175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -146.89 146.29 30.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mp -105.92 -165.08 1.07 Allowed 'General case' 0 C--O 1.231 0.105 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -51.06 139.56 17.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.794 0.33 . . . . 0.0 110.992 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.42 -3.83 80.27 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.621 -0.591 . . . . 0.0 111.621 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.13 10.29 77.9 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 117.362 0.581 . . . . 0.0 112.076 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.05 143.28 52.55 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 117.703 0.752 . . . . 0.0 110.498 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -62.45 142.38 57.92 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 122.962 0.505 . . . . 0.0 110.217 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -143.71 96.82 2.96 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.662 0.267 . . . . 0.0 110.742 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.601 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.8 p -132.65 12.07 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 171.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 66' ' ' THR . 61.4 Cg_endo -69.58 -20.24 35.94 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 121.56 1.507 . . . . 0.0 110.123 -177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.1 m -86.79 -43.82 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.29 -25.72 64.39 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.388 0.54 . . . . 0.0 110.328 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -70.9 -30.83 67.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.53 -29.53 52.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.2 mt -68.93 -30.76 69.28 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.435 0.561 . . . . 0.0 109.813 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.37 -31.06 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.55 48.07 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.091 0.156 . . . . 0.0 110.83 177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -86.97 -0.37 56.47 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.275 0.63 . . . . 0.0 111.013 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.5 t0 57.24 22.52 7.74 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.251 1.02 . . . . 0.0 111.386 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 46.5 mt -81.72 133.07 52.94 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 22.0 Cg_exo -62.6 150.11 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 123.392 2.728 . . . . 0.0 110.985 174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -148.51 150.22 33.01 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.2 t -124.47 147.63 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -97.71 164.56 12.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 173.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.44 139.47 48.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.0 p -143.01 177.52 8.3 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.6 -162.88 11.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.26 -6.74 48.87 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 116.784 0.292 . . . . 0.0 112.551 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 93.9 p -148.8 -9.25 0.35 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.48 0.64 . . . . 0.0 111.034 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -89.79 5.3 46.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.9 p30 -74.81 12.06 0.92 Allowed 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.5 m -77.51 32.67 0.16 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.219 0.608 . . . . 0.0 111.439 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.18 145.2 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-O 120.851 0.357 . . . . 0.0 110.065 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.26 145.07 48.16 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -63.77 -14.02 49.06 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.586 0.354 . . . . 0.0 110.73 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -69.14 -10.8 59.44 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.372 0.669 . . . . 0.0 111.393 176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -131.58 3.63 4.21 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.567 0.167 . . . . 0.0 111.083 -178.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 61.3 mtt-85 -72.66 -11.17 60.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.234 0.47 . . . . 0.0 111.095 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -83.33 5.26 23.94 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.119 0.567 . . . . 0.0 111.406 171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.1 mmp_? -127.96 158.02 72.03 Favored Pre-proline 0 C--O 1.233 0.218 0 C-N-CA 124.325 1.05 . . . . 0.0 109.708 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 97' ' ' ARG . 37.2 Cg_endo -65.13 153.02 80.29 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.901 2.401 . . . . 0.0 111.42 -173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -149.78 127.55 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.04 155.19 20.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 169.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -139.34 -120.51 0.13 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.46 165.54 1.15 Allowed Pre-proline 0 C--O 1.233 0.219 0 C-N-CA 123.925 0.89 . . . . 0.0 110.146 173.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.63 142.98 12.98 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.026 2.484 . . . . 0.0 111.652 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -131.38 154.07 49.0 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -169.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.3 p -82.74 176.7 9.13 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.0 -28.76 69.27 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 177.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -82.93 -21.16 34.19 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.44 -39.44 50.6 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.5 m -76.87 -29.19 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.299 -0.53 . . . . 0.0 110.489 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.62 64.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -70.15 -41.4 73.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.002 0.521 . . . . 0.0 110.395 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.52 -40.18 64.22 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.841 -0.163 . . . . 0.0 110.699 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.4 mt -68.9 -23.62 64.22 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.46 -32.05 54.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 175.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.24 -15.14 62.88 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.504 0.322 . . . . 0.0 110.999 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 75.8 mt -68.01 -14.38 62.93 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 122.149 -0.344 . . . . 0.0 110.88 172.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 117' ' ' LEU . 3.3 mm? -113.34 -0.12 14.63 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.184 0.594 . . . . 0.0 110.181 177.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 92.4 t . . . . . 0 C--O 1.25 1.086 0 CA-C-O 116.854 -1.546 . . . . 0.0 110.239 -169.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 tpp . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.5 t -66.92 157.85 32.2 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 120.866 0.365 . . . . 0.0 110.934 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.55 -2.0 30.22 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.865 0.466 . . . . 0.0 111.29 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.5 tp -153.72 104.71 2.72 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.61 -38.77 0.17 Allowed 'General case' 0 CA--C 1.528 0.102 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.79 113.49 19.03 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.9 mt -130.53 137.3 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 122.599 0.36 . . . . 0.0 110.565 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -96.41 153.39 17.85 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 46.5 mt -124.17 142.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.1 t -133.21 105.17 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -157.94 139.26 13.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -91.79 -30.84 16.0 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -70.85 130.92 87.94 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -67.92 -39.94 10.25 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.507 2.138 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.15 -43.91 93.75 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -174.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.9 mm -73.49 -32.47 36.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.84 -46.15 63.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.511 0.141 . . . . 0.0 110.926 -177.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.7 ptp -73.17 -24.37 60.55 Favored 'General case' 0 C--O 1.226 -0.139 0 O-C-N 122.156 -0.34 . . . . 0.0 110.659 -176.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.8 mmm -74.53 -33.29 62.72 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.142 0.177 . . . . 0.0 110.774 176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.9 mt -73.0 -31.96 64.83 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.07 -31.79 69.56 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 117.7 0.227 . . . . 0.0 110.46 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -75.07 -40.39 60.24 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.412 0.285 . . . . 0.0 110.508 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -69.01 -27.51 65.75 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.82 -39.99 63.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.96 -35.62 78.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.77 -24.42 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 98.6 mt -85.33 15.89 4.06 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.511 0.324 . . . . 0.0 110.448 173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.08 23.03 11.18 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -99.22 178.42 4.91 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.122 0.569 . . . . 0.0 109.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.2 m -130.63 115.43 17.02 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -74.43 92.19 0.94 Allowed 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.954 2.436 . . . . 0.0 108.581 170.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 34.7 m -72.24 -8.37 11.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 C-N-CA 122.067 0.147 . . . . 0.0 111.339 -175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.62 169.64 30.48 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 111.902 -0.479 . . . . 0.0 111.902 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 19.2 m -145.03 138.36 26.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.666 0.787 . . . . 0.0 110.858 177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -138.47 169.83 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 122.49 0.316 . . . . 0.0 110.694 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -131.64 6.07 4.36 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 p -135.89 155.72 49.86 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 123.574 0.75 . . . . 0.0 111.852 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.2 -25.39 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.6 -35.05 78.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.77 -32.05 34.3 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.16 -37.53 69.34 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.147 0.474 . . . . 0.0 110.961 -178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.8 mt -71.36 -35.74 71.23 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.21 -29.85 64.36 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 121.986 0.115 . . . . 0.0 110.723 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -79.14 -44.01 22.84 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.66 -23.16 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 118.083 0.402 . . . . 0.0 111.99 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -82.23 -35.93 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.356 0.263 . . . . 0.0 111.33 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -90.92 -37.81 13.29 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.79 -13.15 82.7 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.562 -0.577 . . . . 0.0 112.89 -171.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.47 34.74 82.48 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.7 mt -66.16 146.16 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 124.1 0.96 . . . . 0.0 111.297 -169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -80.41 -31.36 37.69 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 122.486 0.314 . . . . 0.0 110.55 -173.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 171.71 18.41 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.771 0.428 . . . . 0.0 109.865 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.24 166.08 29.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.996 0.427 . . . . 0.0 111.278 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.42 143.38 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.4 tp -139.4 125.46 19.91 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -78.12 142.55 37.99 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.92 -35.16 72.41 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -127.24 118.87 25.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 mp -86.87 -176.35 5.73 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -52.05 143.7 13.49 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.141 0.496 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.49 -4.6 85.99 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -172.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.87 3.96 61.03 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.289 0.471 . . . . 0.0 112.031 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -73.37 134.91 44.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 117.58 0.69 . . . . 0.0 109.877 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -69.49 152.62 44.63 Favored 'General case' 0 C--N 1.339 0.128 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -145.63 131.47 19.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.595 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.3 p -138.0 9.74 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 171.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.7 Cg_endo -66.46 -25.93 48.0 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 121.751 1.634 . . . . 0.0 110.899 -171.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -90.19 -33.06 5.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.292 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.71 70.0 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.24 0.473 . . . . 0.0 109.861 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -78.25 -27.61 47.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 122.525 0.33 . . . . 0.0 110.341 175.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.02 -37.6 46.63 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.21 0.204 . . . . 0.0 110.498 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.25 -32.96 74.69 Favored 'General case' 0 C--O 1.225 -0.2 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.19 -31.67 61.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.467 -0.146 . . . . 0.0 110.924 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.97 -32.15 57.05 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.565 0.222 . . . . 0.0 110.571 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -83.01 -0.12 47.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.417 0.687 . . . . 0.0 111.376 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 54.5 48.55 20.26 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.649 0.78 . . . . 0.0 111.456 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.19 149.89 70.8 Favored Pre-proline 0 CA--C 1.529 0.145 0 C-N-CA 122.867 0.467 . . . . 0.0 110.171 176.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 20.9 Cg_exo -64.97 155.76 66.25 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.741 2.96 . . . . 0.0 112.597 -175.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -153.51 145.2 23.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 176.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 52.1 t -120.31 148.19 23.6 Favored 'Isoleucine or valine' 0 C--N 1.337 0.053 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -95.79 159.71 14.84 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 171.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.28 140.66 52.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.3 p -141.52 175.99 9.24 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.09 -160.56 25.17 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -62.12 131.78 45.45 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 70.9 m 55.95 11.57 0.74 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.897 0.879 . . . . 0.0 112.863 -176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -123.77 1.63 8.78 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -81.67 11.37 4.83 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.8 m -77.28 36.35 0.19 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.646 0.778 . . . . 0.0 111.385 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.3 143.96 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -73.12 147.52 44.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.8 p -65.19 -12.78 54.82 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 122.603 0.361 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -67.49 -17.81 64.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.128 0.571 . . . . 0.0 110.537 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -128.47 5.49 5.68 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 -174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -72.16 -10.17 59.42 Favored 'General case' 0 CA--C 1.53 0.198 0 O-C-N 122.056 -0.402 . . . . 0.0 110.979 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -85.6 8.67 18.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.263 0.625 . . . . 0.0 111.221 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -126.35 155.76 73.64 Favored Pre-proline 0 C--O 1.233 0.192 0 C-N-CA 124.005 0.922 . . . . 0.0 109.288 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.45 155.88 68.49 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.988 2.459 . . . . 0.0 110.635 -177.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.62 127.47 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.33 155.02 21.51 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -139.82 -120.21 0.12 Allowed 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.14 165.62 1.01 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.563 0.745 . . . . 0.0 110.009 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -47.44 142.72 12.58 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.838 2.359 . . . . 0.0 111.675 -179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -130.97 154.31 48.28 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -169.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -84.18 177.58 8.16 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.84 -28.65 68.98 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -82.99 -21.28 33.96 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.71 -39.25 48.86 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 m -76.82 -28.34 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 117.341 0.57 . . . . 0.0 110.506 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.68 -26.0 62.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -69.54 -39.4 77.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.832 0.453 . . . . 0.0 110.125 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.32 -44.87 62.05 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.614 -0.143 . . . . 0.0 110.614 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -67.41 -28.56 68.02 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.64 -25.74 45.07 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.622 0.192 . . . . 0.0 110.721 176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.69 -14.42 59.62 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.293 -0.255 . . . . 0.0 111.153 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.58 -9.76 57.63 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 122.214 -0.304 . . . . 0.0 111.323 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -97.14 -7.93 31.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.93 0.332 . . . . 0.0 111.464 -177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 m . . . . . 0 C--O 1.253 1.261 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.908 -178.001 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.476 0.858 0 CA-C-O 120.338 0.113 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.6 t -68.02 149.54 49.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.311 0.245 . . . . 0.0 110.437 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -83.58 2.51 36.9 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.618 0.367 . . . . 0.0 111.714 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.5 tp -151.37 105.88 3.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 p -144.7 -32.99 0.4 Allowed 'General case' 0 C--N 1.338 0.071 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.1 mm-40 -81.19 108.06 14.51 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.4 mt -129.5 135.54 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 120.388 0.137 . . . . 0.0 111.212 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 tp -97.1 153.15 18.13 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -124.63 143.19 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.57 110.94 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.13 163.84 35.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.914 0.486 . . . . 0.0 111.086 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.22 -17.89 5.55 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.519 0.728 . . . . 0.0 112.522 174.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -89.6 131.11 40.95 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -66.61 -39.99 14.58 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.398 2.065 . . . . 0.0 111.606 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.74 -41.74 97.99 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.9 mm -75.7 -33.75 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.84 -45.09 75.61 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 122.406 -0.184 . . . . 0.0 110.801 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ptp -74.33 -26.38 60.12 Favored 'General case' 0 C--O 1.227 -0.104 0 CA-C-N 117.638 0.199 . . . . 0.0 110.696 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.1 mmm -76.19 -31.87 58.71 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.536 0.153 . . . . 0.0 111.04 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.0 mt -72.7 -31.89 65.35 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.7 -32.71 70.02 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 175.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -75.07 -35.52 61.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -73.99 -28.71 61.59 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.5 mt -75.28 -38.49 60.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 122.132 -0.355 . . . . 0.0 110.115 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.98 -29.86 65.96 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 117.741 0.246 . . . . 0.0 111.636 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.35 -23.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 118.193 0.452 . . . . 0.0 112.189 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -87.13 15.84 5.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 122.684 0.394 . . . . 0.0 110.366 175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 58.41 22.59 9.67 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -94.07 -172.27 2.78 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.2 m -135.3 109.66 10.5 Favored Pre-proline 0 CA--C 1.53 0.209 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -75.23 93.75 0.97 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.997 2.465 . . . . 0.0 108.579 169.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.34 -5.02 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.42 166.17 20.73 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.357 -0.449 . . . . 0.0 112.059 176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.7 m -141.02 139.12 34.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.376 0.67 . . . . 0.0 111.379 178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.96 166.79 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 122.623 0.369 . . . . 0.0 110.417 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -127.54 2.11 6.21 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -135.01 156.8 48.41 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.74 -24.76 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.34 -35.26 79.03 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.37 -29.75 32.39 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -39.14 67.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.229 0.514 . . . . 0.0 110.796 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 84.9 mt -72.29 -35.39 68.69 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.58 -22.89 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.277 -0.264 . . . . 0.0 110.828 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.8 mmt180 -86.86 -49.45 7.4 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.03 -25.38 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -77.95 -15.13 59.23 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.799 0.272 . . . . 0.0 110.969 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -75.32 -19.28 59.72 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.91 -170.5 52.96 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.441 -0.663 . . . . 0.0 111.441 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.0 0.59 70.18 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -103.17 141.08 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -92.62 -33.3 14.45 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.414 0.286 . . . . 0.0 111.37 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 174.25 14.2 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.445 . . . . 0.0 110.014 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.96 167.69 24.23 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 122.142 -0.349 . . . . 0.0 111.565 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.2 mt -128.26 143.43 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.6 tp -140.3 121.04 14.37 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -73.45 143.17 46.78 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.06 -25.09 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -130.25 136.87 49.65 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.738 0.415 . . . . 0.0 110.053 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -106.05 -164.79 1.04 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -50.64 137.68 19.35 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.063 0.545 . . . . 0.0 110.399 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.39 -0.88 88.62 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.24 5.06 85.0 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-N 117.418 0.609 . . . . 0.0 112.189 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -76.99 139.93 40.25 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 117.633 0.717 . . . . 0.0 110.546 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.407 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -70.66 153.92 42.37 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 122.59 0.356 . . . . 0.0 110.641 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 m -152.96 136.43 15.91 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.307 0.243 . . . . 0.0 111.228 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -138.53 9.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 66' ' ' THR . 55.7 Cg_endo -67.57 -21.16 46.43 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.691 1.594 . . . . 0.0 110.373 -173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.2 m -90.22 -40.13 12.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.96 -26.93 67.8 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.838 0.352 . . . . 0.0 110.254 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -75.2 -25.46 58.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.121 174.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.68 -30.81 32.5 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.551 0.34 . . . . 0.0 110.936 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.13 -33.73 76.08 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.64 -28.63 58.86 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.499 -0.126 . . . . 0.0 110.703 177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.53 -33.01 58.59 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.6 mtt-85 -86.72 2.81 47.36 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.407 0.683 . . . . 0.0 111.495 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t0 53.38 47.93 23.07 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.287 0.635 . . . . 0.0 111.401 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -124.73 148.05 58.02 Favored Pre-proline 0 C--N 1.339 0.121 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.63 156.19 58.66 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 123.526 2.817 . . . . 0.0 112.135 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -151.83 143.77 23.79 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.878 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.39 144.99 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -94.45 157.0 16.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.56 144.72 51.2 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.35 176.28 8.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -125.21 -166.22 12.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.51 -9.41 58.32 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.553 -175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.92 2.87 1.78 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 117.664 0.732 . . . . 0.0 111.577 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -108.25 11.55 27.23 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.8 p30 -70.88 11.22 0.41 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.1 p -82.49 36.39 0.48 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.754 0.822 . . . . 0.0 111.557 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.6 p -57.45 141.59 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -68.54 153.78 43.11 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.565 0.746 . . . . 0.0 110.393 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.3 p -65.21 -15.19 62.2 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.165 0.586 . . . . 0.0 110.802 178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.9 tpt180 -64.84 -16.36 63.03 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.741 0.817 . . . . 0.0 110.876 175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -131.49 5.28 4.36 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 16.6 mmt180 -66.44 -13.56 60.95 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' C ' ' HE ' ' A' ' 97' ' ' ARG . 72.9 m-20 -75.56 -15.11 60.41 Favored 'General case' 0 C--N 1.339 0.121 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -106.85 158.93 31.65 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.825 0.85 . . . . 0.0 108.789 177.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.67 165.37 32.94 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.108 2.539 . . . . 0.0 109.846 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 p -150.36 130.86 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.404 ' HB3' ' CE1' ' A' ' 104' ' ' PHE . 93.2 mt -90.72 154.98 19.15 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.644 0.778 . . . . 0.0 109.129 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.86 -123.99 0.1 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 122.194 -0.316 . . . . 0.0 110.475 -177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.03 165.29 0.39 Allowed Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 123.505 0.722 . . . . 0.0 110.569 174.954 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.3 Cg_exo -46.89 142.2 11.01 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.982 2.455 . . . . 0.0 112.262 -174.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.404 ' CE1' ' HB3' ' A' ' 100' ' ' LEU . 1.3 p90 -133.89 152.03 51.72 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -170.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 p -79.57 175.06 10.95 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.471 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.05 -29.03 69.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -82.94 -21.01 34.21 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.06 -39.47 58.46 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -77.23 -29.06 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 117.222 0.511 . . . . 0.0 111.028 176.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.87 -25.59 62.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.42 -39.38 74.46 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 122.906 0.482 . . . . 0.0 110.092 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.97 -43.42 62.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.805 -0.179 . . . . 0.0 110.837 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.2 mt -68.89 -24.35 64.31 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.206 -0.309 . . . . 0.0 110.602 -178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.13 -25.15 40.03 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.21 59.28 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 122.373 0.269 . . . . 0.0 110.978 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.1 mt -65.86 -15.47 62.95 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.827 -0.545 . . . . 0.0 111.052 175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.17 -12.63 43.37 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.922 0.328 . . . . 0.0 111.19 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 116.914 -1.517 . . . . 0.0 112.673 -178.075 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 110.434 -0.21 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.5 p -154.21 179.63 8.78 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.879 0.471 . . . . 0.0 109.88 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.03 5.98 4.65 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.897 0.479 . . . . 0.0 111.951 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.5 tp -150.22 94.54 2.15 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 p -139.57 -31.93 0.66 Allowed 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -82.46 108.5 15.92 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.5 mt -129.91 134.71 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 O-C-N 122.363 -0.21 . . . . 0.0 111.387 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 tp -96.78 153.34 17.94 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.866 0.467 . . . . 0.0 109.915 174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.6 mt -127.13 143.23 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.2 t -130.88 107.58 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.1 tp10 -155.56 148.79 24.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.077 0.551 . . . . 0.0 109.993 -172.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -109.49 -23.92 11.26 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.0 tp10 -77.51 134.31 66.19 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.1 Cg_exo -61.05 -40.8 48.71 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.816 2.344 . . . . 0.0 111.629 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -69.44 -50.76 42.71 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.37 0.268 . . . . 0.0 111.39 -174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 30.9 mm -67.66 -25.18 32.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 118.1 0.409 . . . . 0.0 109.966 -174.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.54 -48.17 35.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 110.429 -0.211 . . . . 0.0 110.429 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -72.44 -26.11 61.71 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 117.806 0.276 . . . . 0.0 110.683 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.6 mmm -71.48 -37.27 71.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 122.421 -0.175 . . . . 0.0 110.573 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.2 mt -73.56 -33.07 64.49 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.16 -30.16 67.24 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 122.349 -0.219 . . . . 0.0 110.544 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -74.86 -39.78 61.35 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.257 0.223 . . . . 0.0 110.43 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -69.67 -27.02 64.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.8 mt -72.53 -40.27 66.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -69.88 -35.04 74.35 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.72 -24.23 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.829 0.286 . . . . 0.0 111.404 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.4 mt -84.28 12.84 5.99 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.73 0.412 . . . . 0.0 110.739 173.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 58.89 22.64 10.48 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -176.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -94.76 -176.61 3.93 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 m -130.97 114.0 16.29 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.02 93.23 0.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.054 2.503 . . . . 0.0 108.664 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.3 m -75.75 -6.26 8.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.68 18.47 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 112.171 -0.372 . . . . 0.0 112.171 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -141.29 138.06 32.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.704 0.802 . . . . 0.0 111.224 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.5 164.89 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.725 0.41 . . . . 0.0 111.037 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 p30 -127.55 4.56 6.18 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 -177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -136.69 156.81 48.03 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.361 0.665 . . . . 0.0 112.143 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 m -70.52 -24.7 25.69 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.13 -35.97 78.95 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.89 -29.39 42.47 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 177.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.35 -38.18 63.31 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 117.278 0.539 . . . . 0.0 110.979 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.7 mt -71.78 -30.25 65.35 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.22 -26.55 61.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.436 -0.165 . . . . 0.0 110.972 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.5 mmt180 -85.66 -43.74 13.17 Favored 'General case' 0 N--CA 1.458 -0.057 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 p -68.68 -28.79 41.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -80.39 -14.93 57.92 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -69.74 -20.48 63.51 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.05 -174.91 39.76 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.95 -3.59 56.57 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.9 mt -90.94 141.94 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -97.42 -29.24 13.61 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 122.688 0.395 . . . . 0.0 111.007 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.42 171.77 16.6 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.032 0.533 . . . . 0.0 110.162 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.49 168.12 25.14 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.801 0.334 . . . . 0.0 111.051 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.8 mt -130.69 143.42 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.8 tp -135.39 126.02 27.07 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -75.97 141.53 42.2 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.4 -34.95 63.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 122.905 0.482 . . . . 0.0 110.146 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -133.17 118.45 18.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.06 -173.58 4.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 109.971 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.4 ttt85 -53.65 140.68 28.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.687 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 88.95 -4.58 84.85 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.11 4.2 83.01 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 123.369 0.509 . . . . 0.0 112.503 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -77.25 143.62 38.79 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 117.848 0.824 . . . . 0.0 110.758 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.42 142.39 52.02 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 122.983 0.513 . . . . 0.0 110.297 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -145.45 128.97 17.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.687 0.28 . . . . 0.0 111.185 -178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.6 p -138.77 11.77 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.0 Cg_endo -67.79 -22.13 43.56 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.858 1.705 . . . . 0.0 111.09 -171.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -89.93 -41.8 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.86 -26.11 64.97 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 118.247 0.476 . . . . 0.0 110.455 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -70.21 -31.13 68.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.95 -30.41 58.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.3 mt -67.5 -32.77 73.82 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.428 0.558 . . . . 0.0 110.04 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.37 -31.59 65.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.397 0.142 . . . . 0.0 110.748 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.35 -29.64 30.83 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 122.315 -0.241 . . . . 0.0 111.044 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -90.15 4.41 50.53 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.393 0.677 . . . . 0.0 111.007 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.0 t0 56.29 28.54 13.5 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.339 1.056 . . . . 0.0 111.612 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.1 mt -89.26 132.56 37.19 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.46 149.13 90.99 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.815 2.343 . . . . 0.0 110.509 174.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -151.59 153.34 34.3 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.356 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.0 t -130.41 149.68 33.83 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.033 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -95.08 159.42 15.03 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.7 139.57 53.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.47 177.14 8.1 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -147.58 -171.18 16.4 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.31 0.06 9.6 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 122.916 0.293 . . . . 0.0 112.608 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 88.0 p -142.26 6.61 1.73 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.406 0.603 . . . . 0.0 110.892 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -126.66 4.05 6.77 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -69.82 4.92 1.71 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.5 p -80.52 38.53 0.44 Allowed 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.835 0.854 . . . . 0.0 110.411 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.26 144.52 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -70.33 146.56 50.44 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 98.2 p -64.66 -12.8 49.98 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 122.663 0.385 . . . . 0.0 110.525 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -63.89 -16.68 61.99 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.759 0.824 . . . . 0.0 110.651 174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -136.38 8.51 3.14 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -174.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -71.25 -11.22 60.8 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.395 0.543 . . . . 0.0 111.857 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -89.78 2.03 55.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.636 0.374 . . . . 0.0 111.988 172.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -109.0 159.45 31.04 Favored Pre-proline 0 CA--C 1.529 0.156 0 C-N-CA 123.916 0.886 . . . . 0.0 108.708 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.1 150.09 85.39 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.807 2.338 . . . . 0.0 109.91 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -153.18 131.53 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-O 121.09 0.471 . . . . 0.0 110.432 -178.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.414 ' HB3' ' CE2' ' A' ' 104' ' ' PHE . 91.4 mt -95.73 154.46 17.21 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.927 170.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.32 -127.54 0.11 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.305 0.242 . . . . 0.0 110.693 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.413 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -50.05 165.25 0.33 Allowed Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.454 0.702 . . . . 0.0 110.631 174.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 84.4 Cg_exo -46.5 141.87 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.96 2.44 . . . . 0.0 112.126 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CE2' ' HB3' ' A' ' 100' ' ' LEU . 0.9 OUTLIER -133.65 152.98 52.01 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -170.127 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.3 p -75.91 171.06 15.06 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -30.8 70.88 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -80.96 -20.9 40.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 122.623 0.369 . . . . 0.0 111.924 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.79 -42.09 62.05 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.0 m -76.03 -27.37 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 CA-C-N 117.154 0.477 . . . . 0.0 110.85 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.53 -25.22 63.02 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -71.58 -40.0 70.21 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 122.639 0.375 . . . . 0.0 110.265 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.59 -42.26 61.78 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 120.331 0.11 . . . . 0.0 110.898 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.1 -24.77 63.26 Favored 'General case' 0 N--CA 1.456 -0.125 0 O-C-N 122.412 -0.18 . . . . 0.0 110.548 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.56 -28.76 56.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 174.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -71.88 -15.37 62.11 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.137 0.175 . . . . 0.0 110.729 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.9 mt -73.97 -17.3 61.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 119.83 -0.128 . . . . 0.0 111.058 173.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.4 mp -114.4 -16.22 11.98 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 122.52 0.328 . . . . 0.0 111.5 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.675 -1.155 . . . . 0.0 112.364 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.404 0.145 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.8 p -72.3 -6.76 45.45 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.794 0.437 . . . . 0.0 111.332 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.97 1.15 16.06 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.814 0.446 . . . . 0.0 111.56 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.0 tp -150.45 98.93 2.71 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.738 0.415 . . . . 0.0 110.09 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -142.3 -33.57 0.47 Allowed 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -82.25 111.13 18.06 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.7 mt -129.48 134.83 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 CA-C-O 120.62 0.248 . . . . 0.0 111.09 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -97.48 153.19 18.3 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.814 0.446 . . . . 0.0 109.883 174.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 37.4 mt -123.42 141.04 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.0 t -137.96 100.17 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 120.558 0.218 . . . . 0.0 111.012 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -166.71 169.6 13.3 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.01 0.524 . . . . 0.0 109.933 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -107.16 -17.64 14.1 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -77.25 130.46 74.81 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.771 -0.581 . . . . 0.0 109.475 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -70.86 -40.63 3.44 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.881 2.387 . . . . 0.0 111.82 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -62.22 -42.02 98.92 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.3 mm -73.93 -30.18 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.88 63.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 122.35 -0.219 . . . . 0.0 110.72 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.48 -24.5 62.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 89.8 mtp -72.47 -38.86 68.09 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.4 mt -73.25 -28.33 62.08 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.46 -0.15 . . . . 0.0 111.015 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -70.08 -33.73 72.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -74.68 -43.36 55.57 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.689 0.28 . . . . 0.0 111.03 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -70.82 -29.0 65.04 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.8 mt -77.6 -35.52 52.77 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.124 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -75.4 -24.68 57.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.833 0.288 . . . . 0.0 111.632 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.11 -22.34 8.69 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 82.4 mt -85.78 14.97 5.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 122.905 0.482 . . . . 0.0 110.575 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 58.04 22.79 9.29 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -98.78 -174.8 2.88 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.4 m -135.64 112.21 10.7 Favored Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -74.81 97.08 1.03 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 123.082 2.521 . . . . 0.0 108.57 169.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -78.72 -6.44 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.01 168.95 23.6 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.274 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 m -141.3 140.04 33.75 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 123.67 0.788 . . . . 0.0 111.301 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.82 161.56 32.85 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 122.55 0.34 . . . . 0.0 111.016 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -119.42 3.61 11.26 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -136.37 155.76 49.59 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 123.086 0.554 . . . . 0.0 112.387 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -70.6 -24.58 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.36 -34.54 76.25 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.82 -29.22 39.41 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.62 -36.4 57.48 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.247 0.523 . . . . 0.0 110.766 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.8 mt -69.89 -33.5 72.31 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.18 -31.03 63.97 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.747 -0.094 . . . . 0.0 110.747 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 44' ' ' ARG . 9.1 mmt180 -76.39 -43.73 39.35 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.71 -22.93 17.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tp10 -71.47 -27.12 63.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 122.358 -0.213 . . . . 0.0 111.002 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -69.89 -16.47 63.24 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.55 -168.52 45.95 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 175.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.29 -3.65 57.83 Favored Glycine 0 CA--C 1.53 1.019 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 83.7 mt -93.48 142.45 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 117.177 0.488 . . . . 0.0 109.704 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -98.0 -29.84 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.614 0.366 . . . . 0.0 111.062 -175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 172.65 15.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.23 167.57 24.78 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.763 0.316 . . . . 0.0 111.758 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 21.4 mt -126.36 143.41 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -141.98 122.88 14.46 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -174.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -76.13 139.82 41.49 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.88 -29.99 41.89 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -128.67 124.33 35.43 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -92.87 -168.22 1.9 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -52.6 140.22 23.72 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.252 0.621 . . . . 0.0 110.465 -178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.29 -2.66 86.72 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -175.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.96 6.05 85.37 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 117.302 0.551 . . . . 0.0 112.45 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -74.0 141.17 45.85 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.828 0.814 . . . . 0.0 110.687 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -71.13 142.83 50.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.238 0.615 . . . . 0.0 110.382 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -147.48 133.07 18.77 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.596 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.8 p -139.66 11.08 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 171.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 66' ' ' THR . 50.8 Cg_endo -66.67 -27.86 44.8 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 111.816 -169.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.31 -26.54 5.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.126 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.54 -30.29 65.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.702 -0.624 . . . . 0.0 109.611 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -75.94 -28.37 57.95 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 174.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.53 -30.9 59.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.41 -33.42 72.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.03 -28.11 63.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.74 -30.52 36.16 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 120.464 0.173 . . . . 0.0 110.771 178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -88.25 3.11 50.68 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.656 0.782 . . . . 0.0 111.318 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.1 t0 54.77 46.23 25.03 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.636 0.775 . . . . 0.0 111.446 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -125.45 143.51 44.92 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -65.46 153.52 77.83 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.311 2.674 . . . . 0.0 111.515 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -143.53 142.77 31.26 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.1 t -112.06 150.44 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 175.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -103.0 155.62 18.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.04 141.6 51.2 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.5 p -141.03 177.06 8.32 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.83 -159.92 25.27 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.54 129.56 45.12 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m 56.89 10.86 0.82 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.064 0.945 . . . . 0.0 112.47 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -122.39 2.83 9.71 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.2 p30 -84.42 16.77 2.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.05 0.54 . . . . 0.0 112.21 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 88.6 p -78.45 34.95 0.22 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.541 0.737 . . . . 0.0 111.881 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.5 p -61.09 143.52 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -83.04 152.76 25.25 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.1 m -66.1 -17.39 64.67 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 122.607 0.363 . . . . 0.0 111.646 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -75.28 -1.89 25.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.0 0.364 . . . . 0.0 111.037 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -127.04 3.84 6.5 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.3 mmm-85 -71.61 -10.93 60.53 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 117.792 0.269 . . . . 0.0 110.95 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -81.18 1.23 32.95 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 122.75 0.42 . . . . 0.0 111.376 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 97' ' ' ARG . 20.8 mmt180 -122.59 156.37 61.45 Favored Pre-proline 0 N--CA 1.455 -0.202 0 C-N-CA 124.009 0.923 . . . . 0.0 109.848 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.77 161.42 46.12 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.101 2.534 . . . . 0.0 110.336 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.25 127.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.178 0.513 . . . . 0.0 109.876 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.18 152.93 22.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.489 -0.778 . . . . 0.0 108.909 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -139.54 -120.84 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -173.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.44 165.54 1.14 Allowed Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.848 0.859 . . . . 0.0 110.709 175.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -46.53 131.29 15.47 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.879 2.386 . . . . 0.0 110.735 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -118.47 152.04 36.69 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -170.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.58 171.69 14.75 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -32.5 71.42 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -80.98 -20.85 40.98 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.43 -39.6 61.2 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.7 m -75.76 -28.81 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 117.209 0.504 . . . . 0.0 110.476 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.3 -26.36 62.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -72.41 -38.58 68.37 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.505 0.322 . . . . 0.0 110.281 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.33 -41.74 63.12 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.797 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -72.19 -21.12 61.47 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 122.359 -0.213 . . . . 0.0 111.021 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.53 -33.11 54.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.65 -7.02 59.38 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.663 0.385 . . . . 0.0 110.958 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.68 -25.58 56.86 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -89.44 -2.71 58.48 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.697 0.399 . . . . 0.0 111.7 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.337 -178.572 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 ttp . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 t -65.25 157.79 27.98 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.477 0.311 . . . . 0.0 110.75 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.2 -0.53 14.59 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.378 0.271 . . . . 0.0 111.213 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.13 128.66 9.24 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 p -146.92 -46.47 0.18 Allowed 'General case' 0 N--CA 1.458 -0.055 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -77.23 111.01 12.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 118.475 0.58 . . . . 0.0 110.357 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 23.6 mt -130.38 135.92 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 O-C-N 123.301 0.376 . . . . 0.0 110.618 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 tp -97.47 153.0 18.41 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 173.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.07 142.21 44.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.9 t -137.97 114.09 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 C-N-CA 122.682 0.393 . . . . 0.0 110.002 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -158.97 177.06 11.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.415 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -131.3 -7.65 3.78 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.5 tp10 -85.52 133.17 42.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 23.9 Cg_exo -64.03 -39.54 31.53 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.869 2.379 . . . . 0.0 112.308 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.1 mt -69.15 -48.06 63.33 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.437 0.295 . . . . 0.0 111.507 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.3 mm -68.22 -22.69 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.19 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.7 -52.81 15.9 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 122.099 -0.375 . . . . 0.0 110.132 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.9 ptp -72.37 -26.53 61.93 Favored 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 122.403 -0.186 . . . . 0.0 111.129 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.6 mtp -71.91 -40.26 68.94 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 121.209 -0.196 . . . . 0.0 110.902 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.4 mt -74.63 -28.76 61.01 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.446 -0.159 . . . . 0.0 110.821 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -71.22 -33.78 70.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 O-C-N 122.158 -0.339 . . . . 0.0 110.6 175.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -75.23 -44.48 45.88 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.598 0.237 . . . . 0.0 111.207 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.69 -29.44 67.89 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.85 -38.01 58.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.254 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.4 -24.72 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 119.534 -0.269 . . . . 0.0 111.629 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.9 p -84.18 -22.88 7.91 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.9 mt -84.27 15.49 3.55 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 122.697 0.399 . . . . 0.0 110.433 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 58.31 22.38 9.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -97.76 -176.6 3.51 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -136.45 115.28 10.67 Favored Pre-proline 0 N--CA 1.453 -0.294 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -73.77 89.05 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.201 2.601 . . . . 0.0 108.292 169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.6 m -73.33 -4.18 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -172.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.39 161.66 21.33 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.128 176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 m -142.12 135.34 28.96 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.585 0.754 . . . . 0.0 111.587 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 m -138.8 162.87 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 C-N-CA 122.518 0.327 . . . . 0.0 110.861 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.7 p-10 -124.2 4.19 8.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.7 p -134.48 155.74 49.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.44 -25.05 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.77 80.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.94 -30.49 42.75 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.18 -39.18 65.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.302 0.551 . . . . 0.0 110.616 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.69 -29.98 65.17 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.27 -35.39 63.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.78 178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.4 mmm-85 -78.48 -39.11 39.29 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.32 -24.45 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.0 tp10 -78.12 -24.65 47.39 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.355 -0.215 . . . . 0.0 111.072 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -70.04 -11.73 61.1 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.44 -169.8 39.99 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 111.691 -0.563 . . . . 0.0 111.691 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.55 -4.48 56.01 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.1 140.8 18.38 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 CA-C-N 117.277 0.538 . . . . 0.0 109.589 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -110.89 -13.12 14.18 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.44 168.91 21.3 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.352 0.661 . . . . 0.0 109.596 173.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.72 167.48 27.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 122.202 -0.311 . . . . 0.0 111.338 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.1 mt -130.56 143.67 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.86 119.73 13.45 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -172.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -76.22 142.03 41.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -60.66 -33.58 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -117.86 131.35 56.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.227 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.0 mp -106.25 -163.53 0.93 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.614 0.765 . . . . 0.0 108.993 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -49.63 138.01 14.72 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.007 0.523 . . . . 0.0 110.466 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.11 -1.67 86.28 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.45 4.05 73.41 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.685 -0.509 . . . . 0.0 112.47 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -76.07 144.46 40.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 117.902 0.851 . . . . 0.0 110.499 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -71.58 144.77 49.4 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.682 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -149.15 133.25 17.24 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-O 120.804 0.335 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 4.0 p -139.36 13.66 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 173.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.5 Cg_endo -67.3 -21.68 47.32 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.716 1.611 . . . . 0.0 111.06 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 m -88.41 -42.55 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -69.37 -25.58 64.24 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 117.935 0.334 . . . . 0.0 110.47 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -66.95 -31.83 72.67 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 172.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.95 -28.17 39.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.616 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.4 mt -69.41 -29.6 67.37 Favored 'General case' 0 C--N 1.34 0.192 0 O-C-N 121.936 -0.478 . . . . 0.0 109.782 176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.7 -30.68 64.41 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.74 -31.81 46.48 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.247 0.219 . . . . 0.0 111.215 176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -86.3 -2.58 58.53 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.278 0.631 . . . . 0.0 111.097 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.3 t0 57.89 23.78 10.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.123 0.969 . . . . 0.0 111.555 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.7 mt -83.21 137.12 42.85 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -60.85 147.25 95.89 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.255 2.637 . . . . 0.0 110.79 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -150.75 152.84 34.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.384 -0.198 . . . . 0.0 111.349 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.1 t -129.42 144.91 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -92.1 157.59 16.66 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 172.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -123.7 138.7 54.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.5 p -142.35 177.5 8.22 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 122.912 0.485 . . . . 0.0 109.788 -175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.78 -155.94 7.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.56 -13.75 77.71 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.7 m -142.8 -12.55 0.76 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.451 0.625 . . . . 0.0 110.862 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -84.31 6.81 21.53 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.949 0.5 . . . . 0.0 112.269 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.8 p30 -81.66 18.95 1.12 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.7 m -76.67 29.4 0.13 Allowed 'General case' 0 C--N 1.341 0.204 0 C-N-CA 123.565 0.746 . . . . 0.0 111.849 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.29 148.33 11.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 122.728 0.411 . . . . 0.0 110.666 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -74.93 151.34 38.89 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.9 t -65.25 -16.53 63.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.327 -0.233 . . . . 0.0 110.807 178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -64.46 -16.84 63.15 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.699 0.4 . . . . 0.0 110.613 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.94 6.68 6.05 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.625 0.37 . . . . 0.0 111.671 -177.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -70.61 -19.37 62.84 Favored 'General case' 0 CA--C 1.528 0.13 0 O-C-N 122.281 -0.262 . . . . 0.0 111.328 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.9 -25.01 35.34 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 120.841 0.353 . . . . 0.0 111.82 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.27 158.94 76.2 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 123.714 0.806 . . . . 0.0 109.245 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.33 153.55 76.63 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.692 2.261 . . . . 0.0 110.663 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.8 128.59 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 121.153 0.501 . . . . 0.0 110.121 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.0 mt -88.41 153.71 20.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 169.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -138.96 -117.7 0.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -173.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.4 165.31 1.59 Allowed Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 123.797 0.839 . . . . 0.0 110.298 175.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 75.3 Cg_exo -46.58 134.95 16.7 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.962 2.441 . . . . 0.0 111.28 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -124.25 154.07 40.74 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -170.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -82.01 176.4 9.57 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.456 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.2 tpt -62.68 -27.2 69.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -83.01 -24.93 32.64 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.76 -38.79 66.41 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 6.2 m -77.29 -29.64 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 117.392 0.596 . . . . 0.0 110.749 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.0 -25.65 63.7 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -71.48 -39.69 70.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.797 0.439 . . . . 0.0 110.153 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.5 -38.77 62.75 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.041 0.137 . . . . 0.0 110.809 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.3 mt -69.96 -25.75 63.78 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.87 -22.64 39.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 110.511 -0.181 . . . . 0.0 110.511 175.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.78 -13.43 59.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.432 0.293 . . . . 0.0 110.872 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.28 -14.03 45.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 117.957 0.344 . . . . 0.0 110.715 173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.8 mm? -91.18 -0.99 57.8 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.103 0.561 . . . . 0.0 110.466 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 117.458 -1.258 . . . . 0.0 112.277 -178.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ptm . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 120.444 0.164 . . . . 0.0 110.683 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.1 t -69.28 157.75 36.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.521 0.328 . . . . 0.0 110.468 178.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.55 3.39 13.76 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.592 0.357 . . . . 0.0 111.551 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 24.2 tp -150.16 103.53 3.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -141.57 -34.48 0.48 Allowed 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.6 mm-40 -81.97 107.9 15.04 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.3 mt -129.79 133.51 64.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.607 0.242 . . . . 0.0 111.341 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 tp -95.91 153.12 17.92 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 175.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.9 mt -125.28 139.6 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.2 t -135.82 99.81 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 C-N-CA 122.68 0.392 . . . . 0.0 110.305 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -149.94 170.75 18.1 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.093 0.557 . . . . 0.0 110.186 -174.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -123.54 -14.01 7.42 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.127 0.171 . . . . 0.0 111.047 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 44.7 tp10 -81.23 133.2 54.25 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 22.0 Cg_exo -64.8 -41.9 16.84 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.613 2.209 . . . . 0.0 112.185 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 mt -69.79 -47.16 63.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.615 0.366 . . . . 0.0 111.858 -171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.0 mm -70.03 -27.36 32.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -44.36 61.33 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.517 -0.114 . . . . 0.0 110.875 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.7 ptp -73.24 -25.99 60.94 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 122.221 -0.299 . . . . 0.0 110.731 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 90.8 mmm -72.09 -32.57 67.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.3 mt -75.37 -30.15 60.1 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 122.512 -0.117 . . . . 0.0 110.903 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.4 -31.06 68.11 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 122.236 -0.29 . . . . 0.0 110.344 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -75.59 -42.04 52.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.491 0.186 . . . . 0.0 110.707 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.13 -29.62 67.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.65 -37.27 62.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -68.54 -37.58 80.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 111.266 0.098 . . . . 0.0 111.266 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.5 p -76.29 -23.38 15.75 Favored 'Isoleucine or valine' 0 C--N 1.339 0.118 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.1 mt -85.59 14.1 6.12 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.654 0.382 . . . . 0.0 110.559 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 59.0 22.93 10.98 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -96.52 -174.27 2.99 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -133.33 113.05 13.19 Favored Pre-proline 0 N--CA 1.452 -0.353 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -174.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.0 85.58 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.123 2.549 . . . . 0.0 108.585 170.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -69.88 -7.52 8.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 166.61 20.65 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 121.4 -0.428 . . . . 0.0 112.103 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.5 m -142.12 138.57 31.74 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.864 0.866 . . . . 0.0 111.125 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 m -137.18 166.29 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.559 0.343 . . . . 0.0 111.043 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -127.1 3.52 6.47 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.45 157.33 47.17 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.219 0.607 . . . . 0.0 112.445 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.93 -25.59 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.57 -33.74 74.61 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.89 -31.1 27.26 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.09 -36.43 64.26 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 117.185 0.492 . . . . 0.0 110.887 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.16 -36.78 69.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.24 -22.83 65.67 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 122.366 -0.209 . . . . 0.0 110.595 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 44' ' ' ARG . 10.3 mmt180 -86.6 -48.5 8.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.59 -26.8 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -76.5 -14.83 60.01 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.212 -0.305 . . . . 0.0 111.033 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -75.47 -18.98 59.7 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.61 -169.56 51.97 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.38 -0.95 67.12 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 79.3 mt -100.71 141.8 16.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 C-N-CA 123.126 0.57 . . . . 0.0 109.629 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -92.1 -34.24 14.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.289 0.236 . . . . 0.0 111.456 -175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.27 173.17 16.1 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.927 0.491 . . . . 0.0 110.099 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.83 23.49 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.745 0.307 . . . . 0.0 111.665 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -130.83 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.425 0.69 . . . . 0.0 109.276 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.0 tp -141.4 127.12 19.1 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -79.37 147.47 32.38 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.53 -30.65 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -130.05 137.1 50.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 122.902 0.481 . . . . 0.0 109.991 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.43 -164.15 1.0 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.727 0.811 . . . . 0.0 109.051 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -50.02 139.62 13.69 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.637 0.375 . . . . 0.0 110.358 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.26 0.41 86.28 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.17 6.27 86.02 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-N 117.576 0.688 . . . . 0.0 111.978 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.31 137.99 43.23 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.54 0.67 . . . . 0.0 110.397 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 160.76 30.24 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 122.307 0.243 . . . . 0.0 110.549 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -149.87 126.13 10.73 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.635 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -136.31 4.65 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 168.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 66' ' ' THR . 42.6 Cg_endo -66.1 -29.25 48.29 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.162 1.908 . . . . 0.0 110.738 -173.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.434 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -87.91 -35.79 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.81 70.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 118.186 0.448 . . . . 0.0 110.009 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -77.81 -26.33 49.49 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.401 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.64 -32.09 41.61 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.289 0.236 . . . . 0.0 110.8 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -66.39 -35.27 79.89 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 174.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.72 -30.11 62.65 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.679 -0.119 . . . . 0.0 110.679 177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.18 -34.6 61.56 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.209 0.204 . . . . 0.0 110.576 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.1 mtt-85 -85.27 2.29 44.62 Favored 'General case' 0 N--CA 1.458 -0.061 0 C-N-CA 123.168 0.587 . . . . 0.0 111.419 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 40.2 t0 54.54 47.45 22.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.344 0.658 . . . . 0.0 111.224 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 77' ' ' ILE . 0.7 OUTLIER -125.2 142.39 41.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -63.87 156.86 55.65 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.461 2.774 . . . . 0.0 112.263 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -151.25 150.87 31.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.6 149.4 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 C-N-CA 123.194 0.597 . . . . 0.0 109.528 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -98.55 164.82 12.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.56 140.67 49.52 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 36.1 p -142.34 177.69 8.09 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.91 -156.97 6.99 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.44 -2.64 43.55 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 174.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 98.5 p -150.94 173.96 13.68 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 108.498 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 57.9 15.21 2.95 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -76.68 11.82 1.53 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.142 0.577 . . . . 0.0 112.147 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 85.3 p -78.23 43.74 0.46 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.921 0.889 . . . . 0.0 111.543 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.43 144.57 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -69.56 153.88 42.83 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 -171.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.7 p -65.46 -15.34 62.53 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 122.709 0.403 . . . . 0.0 110.299 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -64.47 -17.3 63.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.709 0.804 . . . . 0.0 110.515 174.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -134.19 8.62 3.73 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -67.47 -16.46 64.23 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.293 0.497 . . . . 0.0 111.507 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -82.33 -10.76 58.96 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -87.43 155.8 53.97 Favored Pre-proline 0 C--N 1.34 0.171 0 C-N-CA 122.962 0.505 . . . . 0.0 110.051 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -69.27 157.57 60.85 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 123.092 2.528 . . . . 0.0 109.292 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -150.68 128.36 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.117 0.484 . . . . 0.0 110.103 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.13 155.19 21.58 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 170.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -139.24 -124.86 0.12 Allowed 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.341 -0.225 . . . . 0.0 110.395 -173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.4 165.1 1.22 Allowed Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.971 0.909 . . . . 0.0 110.784 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.32 115.27 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 123.071 2.514 . . . . 0.0 111.337 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -99.7 155.92 17.36 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -172.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.52 177.04 8.61 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.1 tpt -62.57 -26.91 68.83 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.236 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -82.8 -24.08 33.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.78 -38.7 56.49 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.2 m -76.09 -29.58 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 117.45 0.625 . . . . 0.0 110.482 176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.89 -24.59 64.33 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -72.47 -41.35 66.14 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.757 0.423 . . . . 0.0 110.257 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.31 -42.56 59.29 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 110.677 -0.12 . . . . 0.0 110.677 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.05 -27.4 67.36 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.27 -29.43 57.43 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -72.66 -14.8 61.67 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.15 0.18 . . . . 0.0 110.904 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.2 mt -77.79 -14.1 59.69 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.161 -0.337 . . . . 0.0 111.325 173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -116.6 -14.87 10.86 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.776 0.43 . . . . 0.0 111.423 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.301 -178.198 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.1 p 47.59 34.27 3.48 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.92 0.888 . . . . 0.0 112.393 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.32 12.19 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.854 0.462 . . . . 0.0 111.538 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' ' HE3' ' A' ' 29' ' ' LYS . 30.3 mt -66.23 147.36 53.44 Favored 'General case' 0 C--N 1.336 -0.016 0 C-N-CA 123.418 0.687 . . . . 0.0 109.723 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -135.81 -41.05 0.68 Allowed 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -84.96 102.36 13.1 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.7 mt -129.11 130.82 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.338 -0.226 . . . . 0.0 111.149 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.75 153.06 19.88 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -124.79 141.54 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.2 t -136.02 106.58 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -154.94 138.23 15.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -171.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -91.65 -28.23 17.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -78.2 133.0 65.18 Favored Pre-proline 0 C--O 1.233 0.232 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -67.68 -40.02 10.76 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.561 2.174 . . . . 0.0 111.503 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.15 -44.56 91.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 119.827 -0.13 . . . . 0.0 111.234 -173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.1 mm -73.81 -28.71 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.29 -46.91 38.18 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.286 0.235 . . . . 0.0 110.813 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -71.31 -24.32 62.11 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -38.19 73.13 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.576 -0.157 . . . . 0.0 110.576 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.8 mt -71.24 -30.59 66.51 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.422 -0.174 . . . . 0.0 110.732 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.75 -33.49 68.7 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 122.314 -0.241 . . . . 0.0 110.598 177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -75.81 -40.78 54.37 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.607 0.363 . . . . 0.0 110.667 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -70.28 -29.3 66.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -72.49 -38.71 68.07 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -68.27 -37.45 80.73 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.2 -0.312 . . . . 0.0 111.54 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 p -75.23 -22.98 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.6 mt -86.59 14.77 6.37 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.792 0.437 . . . . 0.0 110.61 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 58.52 23.34 10.67 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 4' ' ' LEU . 60.1 mttp -98.07 -178.69 4.15 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.322 0.649 . . . . 0.0 109.363 176.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -127.33 114.89 21.46 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -175.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.63 83.26 2.1 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.367 2.711 . . . . 0.0 108.324 169.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.9 m -70.08 -7.05 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -172.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.8 161.33 15.69 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.052 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.9 m -142.23 137.7 30.92 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.647 0.779 . . . . 0.0 111.506 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -138.3 160.33 32.03 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 C-N-CA 122.659 0.384 . . . . 0.0 111.098 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 p30 -121.92 1.43 9.87 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 p -127.74 148.99 50.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.094 0.558 . . . . 0.0 111.806 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.14 -24.67 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -173.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.1 64.06 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.93 -31.26 35.91 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.98 -35.08 64.44 Favored 'General case' 0 C--O 1.232 0.137 0 O-C-N 122.634 -0.333 . . . . 0.0 110.147 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.3 mt -70.02 -34.27 73.07 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.85 -25.4 60.05 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.006 -0.088 . . . . 0.0 110.937 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -82.59 -41.03 20.05 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.4 p -72.3 -23.88 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.855 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -77.13 -14.94 59.72 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -72.55 -18.34 61.64 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.032 -0.418 . . . . 0.0 112.117 174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.22 -175.19 32.82 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 112.062 -0.415 . . . . 0.0 112.062 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.77 -1.0 63.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.2 mt -91.05 140.56 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.194 0.497 . . . . 0.0 110.086 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -90.92 -35.68 14.58 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.605 0.362 . . . . 0.0 111.025 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.08 174.26 13.23 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.931 0.493 . . . . 0.0 109.974 -177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.48 168.23 23.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.837 0.351 . . . . 0.0 111.426 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 22.8 mt -128.42 143.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.5 tp -141.18 129.75 22.68 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -171.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -81.54 151.24 27.83 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.19 -28.43 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.093 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -142.63 140.86 31.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.9 mp -105.62 -166.52 1.22 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -50.09 137.5 17.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.54 -3.29 86.87 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.13 6.17 82.4 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 117.232 0.516 . . . . 0.0 112.37 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -74.56 143.89 44.27 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.047 0.923 . . . . 0.0 110.648 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.38 146.21 54.28 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.95 0.5 . . . . 0.0 110.235 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -146.6 122.53 10.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.508 0.323 . . . . 0.0 110.496 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.2 p -137.45 7.08 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 173.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.6 Cg_endo -68.33 -23.19 38.68 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.938 1.759 . . . . 0.0 110.729 -173.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.7 m -87.6 -29.03 5.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.38 63.6 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -75.35 -29.87 60.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.22 63.27 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.497 0.319 . . . . 0.0 110.535 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.72 -33.59 72.69 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.54 -30.29 64.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 122.459 -0.151 . . . . 0.0 110.782 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.04 -26.67 33.54 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.264 0.226 . . . . 0.0 111.056 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.403 ' HG3' HH11 ' A' ' 75' ' ' ARG . 54.0 mtt85 -91.6 5.12 50.83 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 123.395 0.678 . . . . 0.0 111.41 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.37 45.09 27.89 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.458 0.703 . . . . 0.0 111.556 178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.46 139.01 32.08 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.94 155.05 70.1 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.304 2.67 . . . . 0.0 112.032 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -147.35 144.46 28.76 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 81.4 t -116.0 149.45 18.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -98.38 157.71 16.03 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.25 143.07 50.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.3 p -150.02 177.24 10.05 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -161.86 -161.69 12.23 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.97 134.79 49.15 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.4 m 56.98 8.22 0.49 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.985 0.914 . . . . 0.0 113.011 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -117.66 9.38 13.07 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.167 0.587 . . . . 0.0 112.497 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p30 -73.52 14.33 0.36 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.2 p -78.1 30.76 0.17 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.065 0.946 . . . . 0.0 111.719 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.44 144.51 11.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -70.7 144.85 50.88 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.5 m -69.34 -9.16 52.11 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 -71.79 -8.22 52.95 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.424 0.29 . . . . 0.0 111.002 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -136.95 10.22 3.06 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -72.57 -8.69 56.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.55 0.614 . . . . 0.0 111.769 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -85.94 -14.08 45.78 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.399 0.28 . . . . 0.0 111.724 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -83.93 159.96 59.08 Favored Pre-proline 0 C--O 1.232 0.171 0 C-N-CA 123.444 0.697 . . . . 0.0 109.862 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.85 148.91 77.68 Favored 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 122.645 2.23 . . . . 0.0 108.688 171.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.9 p -151.65 127.07 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 121.569 0.7 . . . . 0.0 110.397 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 84.2 mt -81.72 136.28 35.47 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 169.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -141.25 3.96 1.79 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.58 165.37 14.09 Favored Pre-proline 0 C--N 1.333 -0.147 0 O-C-N 121.635 -0.665 . . . . 0.0 109.67 -173.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -54.69 105.91 0.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.577 2.185 . . . . 0.0 109.84 174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -93.34 150.56 20.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 115.242 1.571 . . . . 0.0 115.242 -172.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.6 p -85.74 175.45 8.7 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 123.217 0.607 . . . . 0.0 112.333 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.6 tpt -60.54 -30.87 70.04 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -83.15 -20.98 33.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.18 -38.2 35.23 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.5 m -76.27 -29.47 19.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 117.422 0.611 . . . . 0.0 110.126 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.74 62.87 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -73.45 -38.72 65.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.428 0.291 . . . . 0.0 110.452 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.33 -42.28 59.71 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.859 -0.155 . . . . 0.0 110.927 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.84 -21.86 63.33 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 122.41 -0.181 . . . . 0.0 110.815 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.43 -34.14 36.31 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 174.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.13 -14.6 63.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.626 0.37 . . . . 0.0 111.376 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.72 -17.44 64.56 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 122.34 -0.225 . . . . 0.0 110.629 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.3 mm? -113.91 -36.77 4.69 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.767 0.427 . . . . 0.0 109.876 178.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 C--O 1.252 1.211 0 CA-C-O 116.993 -1.479 . . . . 0.0 110.255 -176.255 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 tpp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.634 -0.136 . . . . 0.0 110.634 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.4 t -155.93 158.16 37.49 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 122.454 0.301 . . . . 0.0 110.288 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.82 0.94 18.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.777 0.431 . . . . 0.0 111.178 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 tp -148.17 107.48 3.91 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.9 p -142.07 -34.22 0.47 Allowed 'General case' 0 C--O 1.228 -0.056 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.398 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.63 111.46 22.98 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 61.3 mt -129.65 128.49 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 122.464 0.306 . . . . 0.0 110.607 -175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -88.32 152.84 21.66 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.6 mt -125.08 141.75 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -134.45 110.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 122.581 0.352 . . . . 0.0 110.056 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -142.43 167.24 22.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 123.474 0.71 . . . . 0.0 109.857 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -122.45 8.84 9.62 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 173.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -124.12 133.67 24.86 Favored Pre-proline 0 N--CA 1.454 -0.236 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -66.87 -37.77 19.1 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.579 2.186 . . . . 0.0 111.422 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.33 -43.14 98.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 119.749 -0.167 . . . . 0.0 110.647 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 38.5 mm -73.34 -32.22 36.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.78 -47.94 50.06 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 121.915 0.086 . . . . 0.0 110.98 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.6 ptp -70.61 -24.51 62.75 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.26 -0.275 . . . . 0.0 110.555 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 82.2 mmm -72.45 -33.81 67.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.3 mt -77.64 -32.83 53.58 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.458 -0.151 . . . . 0.0 110.674 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.92 -31.76 70.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.624 0.193 . . . . 0.0 110.727 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -72.77 -41.71 64.75 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.539 0.209 . . . . 0.0 110.836 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -70.53 -24.89 62.9 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -74.22 -40.6 62.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -69.84 -29.41 66.65 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -81.99 -23.05 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 91.4 mt -87.87 17.08 5.11 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.552 0.341 . . . . 0.0 110.708 175.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 59.18 22.68 10.9 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -176.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -98.06 -176.71 3.51 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 175.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -132.28 115.32 15.02 Favored Pre-proline 0 N--CA 1.455 -0.179 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -73.11 89.55 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 123.011 2.474 . . . . 0.0 108.951 170.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 HD12 ' A' ' 50' ' ' ILE . 11.9 m -69.21 -14.4 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.036 0.535 . . . . 0.0 110.532 -175.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.47 173.07 29.66 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 25.9 m -145.23 140.74 28.08 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.437 0.695 . . . . 0.0 110.719 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -136.21 170.37 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 122.633 0.373 . . . . 0.0 110.534 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -131.58 5.16 4.32 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 p -137.2 156.33 48.45 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.006 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -70.55 -25.03 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.68 -34.7 77.43 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.57 -32.48 30.49 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.27 -35.68 68.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.223 0.512 . . . . 0.0 110.623 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.91 -35.73 69.79 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.62 -26.02 60.58 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 111.31 0.115 . . . . 0.0 111.31 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 71.4 mmt-85 -87.01 -35.7 18.65 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.27 -22.51 15.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.559 0.618 . . . . 0.0 111.885 177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -82.6 -22.03 34.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 122.642 0.377 . . . . 0.0 111.742 178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -120.31 -27.77 5.17 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.21 -9.34 86.18 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 119.561 -0.577 . . . . 0.0 112.854 -172.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.71 36.63 92.98 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 HG21 ' A' ' 32' ' ' VAL . 4.4 mm -66.45 148.17 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 123.318 0.647 . . . . 0.0 110.885 -172.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -88.23 -31.73 18.9 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.598 0.359 . . . . 0.0 110.441 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.49 171.71 17.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.7 165.97 28.01 Favored 'General case' 0 C--O 1.232 0.141 0 O-C-N 121.986 -0.446 . . . . 0.0 111.824 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.2 143.27 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.0 tp -145.25 123.34 12.12 Favored 'General case' 0 C--N 1.337 0.05 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -171.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -77.5 144.45 37.68 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 174.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.1 t -61.08 -31.96 51.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -126.86 135.32 50.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -104.9 -171.11 1.86 Allowed 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -52.23 142.59 16.37 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.772 0.32 . . . . 0.0 110.732 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.86 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -172.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.53 4.29 64.83 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.689 0.661 . . . . 0.0 112.628 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -77.06 146.82 37.05 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.743 0.771 . . . . 0.0 110.597 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 154.65 39.27 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 122.671 0.388 . . . . 0.0 110.866 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -150.29 127.44 11.25 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.2 p -138.02 9.53 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 169.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 44.9 Cg_endo -64.7 -25.97 61.1 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.726 1.617 . . . . 0.0 110.978 -169.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.9 m -89.71 -32.83 5.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.253 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.12 -27.78 69.32 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.496 0.589 . . . . 0.0 109.668 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -76.92 -30.49 56.14 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.72 -36.91 56.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.631 0.372 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.72 -35.1 79.78 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.71 -31.99 65.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.49 -0.131 . . . . 0.0 111.101 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.94 -30.72 56.19 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.317 -0.24 . . . . 0.0 110.613 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 -85.62 1.87 47.42 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 123.509 0.724 . . . . 0.0 111.211 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.1 t0 55.14 46.75 23.28 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.542 0.737 . . . . 0.0 111.723 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 0.7 OUTLIER -127.34 145.4 54.28 Favored Pre-proline 0 CA--C 1.53 0.178 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 176.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 16.0 Cg_exo -67.2 157.36 62.08 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.632 2.888 . . . . 0.0 111.742 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -152.87 142.76 22.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -108.73 147.41 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 123.027 0.531 . . . . 0.0 109.588 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -96.88 155.49 16.75 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 170.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -124.52 145.4 49.58 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 57.7 p -142.64 177.3 8.4 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.43 -161.48 25.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -60.3 129.7 47.85 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 p 52.57 12.39 0.24 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.031 1.333 . . . . 0.0 112.757 -175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -118.48 3.75 11.8 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -86.01 15.72 4.79 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.8 m -78.01 33.08 0.18 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.466 0.706 . . . . 0.0 112.069 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.63 144.92 12.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-O 120.902 0.382 . . . . 0.0 110.293 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -67.27 146.42 54.16 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.961 0.504 . . . . 0.0 109.712 -173.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.4 p -66.6 -19.47 65.78 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 122.987 0.515 . . . . 0.0 111.059 -177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.5 ttt-85 -73.22 -9.54 58.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.961 0.504 . . . . 0.0 110.777 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -125.94 8.57 7.44 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -67.22 -13.35 61.88 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.388 0.275 . . . . 0.0 111.339 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -85.57 -15.76 41.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.859 0.464 . . . . 0.0 112.067 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -77.17 156.21 81.92 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.508 2.139 . . . . 0.0 109.286 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.54 127.73 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.381 0.61 . . . . 0.0 110.408 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.53 152.61 21.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.804 169.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -139.55 -117.49 0.13 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -56.14 165.68 1.38 Allowed Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.948 0.899 . . . . 0.0 110.099 173.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.5 Cg_exo -47.25 143.88 10.12 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.985 2.457 . . . . 0.0 111.791 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -132.42 153.54 50.72 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.8 p -85.46 176.74 8.07 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 112.905 0.705 . . . . 0.0 112.905 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.483 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.59 -29.82 69.43 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.262 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -83.07 -22.04 33.58 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.8 -38.25 50.04 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -78.23 -27.92 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 117.317 0.559 . . . . 0.0 110.66 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.79 -28.07 63.36 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -69.79 -39.3 76.69 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.758 0.423 . . . . 0.0 110.49 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.74 -41.04 65.59 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.951 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -74.79 -24.83 58.72 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.637 -0.135 . . . . 0.0 110.637 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -40.78 63.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -73.63 -13.85 61.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 122.83 0.452 . . . . 0.0 110.781 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 30.9 tp -77.44 -26.42 51.51 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.045 -0.409 . . . . 0.0 111.311 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.39 -11.79 14.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.684 0.394 . . . . 0.0 111.244 -176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.188 -177.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 t -155.29 157.08 36.65 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 122.513 0.325 . . . . 0.0 110.3 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.87 1.36 31.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.698 0.399 . . . . 0.0 111.116 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 34.1 tp -151.87 109.07 3.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -151.12 -42.18 0.12 Allowed 'General case' 0 C--O 1.227 -0.101 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -77.8 113.9 16.13 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 118.192 0.451 . . . . 0.0 110.073 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.3 mt -129.58 135.08 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.37 0.268 . . . . 0.0 110.335 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -95.22 153.31 17.72 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.3 mt -125.91 143.24 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.65 107.23 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -144.83 155.86 43.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.485 0.714 . . . . 0.0 109.463 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -111.06 0.33 16.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.0 tp10 -110.37 133.59 21.05 Favored Pre-proline 0 N--CA 1.453 -0.306 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.1 -37.29 19.17 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.49 2.127 . . . . 0.0 111.417 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -64.5 -42.82 95.61 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.791 -174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.5 mm -74.19 -30.23 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.073 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.8 -48.63 45.11 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 122.488 -0.133 . . . . 0.0 110.927 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 ptp -71.71 -24.17 61.76 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.295 -0.253 . . . . 0.0 110.764 -176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.6 mmm -73.15 -34.28 65.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.161 0.184 . . . . 0.0 110.83 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.32 -33.51 59.02 Favored 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 122.384 -0.198 . . . . 0.0 110.636 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.58 -31.51 70.76 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.269 -0.269 . . . . 0.0 110.487 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -74.36 -42.22 59.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.196 0.198 . . . . 0.0 110.794 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -69.3 -26.88 64.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 80.7 mt -73.43 -40.2 64.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -68.22 -34.86 77.03 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -77.1 -24.23 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 O-C-N 122.198 -0.314 . . . . 0.0 111.606 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.6 mt -85.24 14.51 5.14 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.433 0.293 . . . . 0.0 110.344 173.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 59.27 23.41 11.8 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -95.73 -175.8 3.54 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m -133.67 113.34 12.92 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.4 91.51 1.05 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.422 2.748 . . . . 0.0 108.781 170.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 m -75.83 -6.76 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 165.72 165.31 22.84 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.341 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.9 m -143.3 138.2 29.37 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.873 0.869 . . . . 0.0 111.124 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -136.37 160.89 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 O-C-N 123.147 0.28 . . . . 0.0 111.228 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 16.9 p30 -124.16 4.67 8.55 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.9 p -130.04 147.79 51.82 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.088 0.555 . . . . 0.0 111.17 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 p -73.68 -24.61 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.83 -25.56 62.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.48 -30.52 40.31 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.17 -34.33 61.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.993 0.396 . . . . 0.0 110.259 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 mt -70.11 -32.65 70.78 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.72 -29.63 58.98 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.085 0.154 . . . . 0.0 110.659 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -76.79 -43.46 36.71 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.65 -24.08 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.9 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.4 tp10 -72.45 -25.61 61.51 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 122.396 -0.19 . . . . 0.0 110.833 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -71.55 -15.96 62.3 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.25 -169.27 46.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.63 -4.06 57.73 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.5 mt -95.42 143.81 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 117.286 0.543 . . . . 0.0 109.793 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -103.8 -25.89 12.92 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.431 0.293 . . . . 0.0 111.022 -175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 172.1 16.32 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 122.931 0.492 . . . . 0.0 109.868 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.33 165.97 31.44 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 121.937 -0.477 . . . . 0.0 111.641 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.18 143.3 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.0 tp -143.27 126.08 16.12 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -170.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -79.31 142.94 35.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.8 t -62.02 -28.72 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 122.901 0.48 . . . . 0.0 110.077 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -136.48 137.46 40.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.7 mp -106.17 -170.31 1.71 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -52.65 144.53 13.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 81.78 -3.4 79.58 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 -173.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.42 4.95 76.15 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 117.26 0.53 . . . . 0.0 112.092 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -70.51 141.17 51.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 117.47 0.635 . . . . 0.0 109.987 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.33 159.15 33.68 Favored 'General case' 0 C--N 1.339 0.145 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -146.31 112.95 5.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.061 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -134.83 4.57 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 66' ' ' THR . 60.7 Cg_endo -69.98 -26.5 26.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.499 1.466 . . . . 0.0 110.958 -173.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.7 m -87.39 -28.75 5.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.447 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.44 64.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -76.52 -28.73 56.49 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.338 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.38 -31.89 58.27 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.17 -33.19 73.0 Favored 'General case' 0 C--O 1.228 -0.079 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -28.87 62.39 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.96 -30.05 35.25 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.069 0.148 . . . . 0.0 110.747 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.8 mtt-85 -88.54 3.96 48.47 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.38 0.672 . . . . 0.0 111.291 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.0 t0 54.45 46.37 25.13 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.401 0.68 . . . . 0.0 111.417 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -125.48 143.14 43.8 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -65.21 153.44 78.27 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.583 2.855 . . . . 0.0 112.182 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -146.75 150.21 34.89 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 122.752 0.421 . . . . 0.0 112.121 177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.1 t -125.69 141.6 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -89.82 162.75 15.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 173.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -133.55 143.08 48.49 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.3 p -140.56 177.18 8.2 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.66 -164.99 10.92 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.9 -12.15 74.66 Favored Glycine 0 CA--C 1.53 1.028 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.7 m -143.18 -10.7 0.75 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.479 0.64 . . . . 0.0 111.302 177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -87.17 7.28 28.9 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.889 0.476 . . . . 0.0 112.09 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.4 p30 -77.12 15.07 0.76 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.33 0.652 . . . . 0.0 112.706 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.2 t -76.72 36.28 0.16 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.5 0.72 . . . . 0.0 110.547 177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.53 148.82 8.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.125 0 C-N-CA 123.028 0.531 . . . . 0.0 110.37 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -69.64 145.52 52.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.1 p -64.59 -13.07 51.5 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.533 0.206 . . . . 0.0 110.703 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -68.14 -14.18 62.79 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.445 0.698 . . . . 0.0 111.083 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -133.22 6.93 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.614 0.188 . . . . 0.0 111.172 -175.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -70.76 -9.4 57.27 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.154 0.433 . . . . 0.0 111.677 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.4 p30 -89.88 -14.36 34.44 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.878 0.471 . . . . 0.0 111.613 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.5 mmt-85 -81.62 156.9 70.38 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.22 153.64 74.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.751 2.301 . . . . 0.0 109.489 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.33 126.99 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.384 0.611 . . . . 0.0 110.36 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.2 mt -85.87 154.91 21.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.465 -0.789 . . . . 0.0 108.95 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -139.64 -121.8 0.12 Allowed 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.103 -0.373 . . . . 0.0 110.028 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.41 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.44 165.59 0.85 Allowed Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 123.566 0.746 . . . . 0.0 110.412 173.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 73.4 Cg_exo -47.12 142.7 11.2 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.58 154.42 47.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -169.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.2 p -83.12 176.48 9.17 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 123.271 0.628 . . . . 0.0 112.609 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.478 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.35 -29.27 69.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.21 -22.17 33.23 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.67 56.62 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.2 m -78.74 -29.33 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-N 117.336 0.568 . . . . 0.0 110.475 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.13 -27.13 64.32 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -69.6 -39.95 76.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.625 0.37 . . . . 0.0 110.538 178.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.02 -41.21 62.19 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.363 0.125 . . . . 0.0 110.988 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.43 -23.17 62.68 Favored 'General case' 0 N--CA 1.457 -0.083 0 O-C-N 122.448 -0.157 . . . . 0.0 110.634 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.36 -30.49 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.37 -14.93 63.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.602 0.361 . . . . 0.0 110.744 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.45 -5.15 17.67 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.454 -0.153 . . . . 0.0 110.738 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mp -131.04 -37.28 1.29 Allowed 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.954 0.502 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 C--O 1.249 1.039 0 CA-C-O 116.97 -1.49 . . . . 0.0 109.909 -178.36 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.768 -0.086 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.35 155.47 33.72 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.663 0.385 . . . . 0.0 110.294 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -81.1 4.6 19.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.845 0.458 . . . . 0.0 111.157 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -148.0 101.24 3.27 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -140.65 -32.04 0.59 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.0 107.36 15.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.3 mt -129.57 134.46 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 O-C-N 122.386 -0.197 . . . . 0.0 111.37 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tp -97.83 153.27 18.42 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 mt -127.0 141.02 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.36 116.04 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 C-N-CA 122.662 0.385 . . . . 0.0 110.202 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -154.74 178.64 9.9 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -137.12 32.0 2.65 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 86.6 tt0 -137.02 134.23 18.94 Favored Pre-proline 0 C--O 1.232 0.18 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 175.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 25.8 Cg_exo -63.24 -40.06 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.803 2.335 . . . . 0.0 112.198 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.0 mt -66.36 -45.21 80.94 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 122.506 0.322 . . . . 0.0 111.285 -175.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.8 mm -70.37 -25.31 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.85 -52.38 15.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 122.092 0.157 . . . . 0.0 110.654 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -70.26 -24.72 63.11 Favored 'General case' 0 CA--C 1.527 0.091 0 O-C-N 122.48 -0.138 . . . . 0.0 111.025 -175.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -70.31 -43.97 69.25 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 176.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 86.7 mt -74.65 -28.62 60.94 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-O 119.782 -0.152 . . . . 0.0 111.073 -177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -71.87 -32.3 67.34 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 117.88 0.309 . . . . 0.0 110.595 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -74.61 -42.94 57.74 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.622 0.249 . . . . 0.0 110.699 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.2 -29.08 65.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.6 mt -74.38 -36.37 63.54 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.056 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -70.35 -34.76 73.02 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.423 -0.173 . . . . 0.0 111.409 -176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.8 p -77.77 -24.27 14.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 O-C-N 122.226 -0.296 . . . . 0.0 111.559 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.17 12.81 4.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.819 0.447 . . . . 0.0 110.356 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 58.56 22.79 10.13 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp -95.25 -174.13 3.13 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -130.13 113.89 17.32 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.55 89.24 1.22 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.923 2.415 . . . . 0.0 108.203 169.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 m -75.26 -4.91 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 166.32 161.26 14.99 Favored Glycine 0 C--N 1.334 0.466 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.0 m -141.89 135.25 29.29 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 123.511 0.724 . . . . 0.0 111.569 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.97 167.14 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 122.691 0.396 . . . . 0.0 111.403 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -129.02 3.81 5.3 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.942 1.089 . . . . 0.0 113.942 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -135.86 156.74 48.32 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.196 0.598 . . . . 0.0 112.177 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.92 -24.95 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.45 -36.39 81.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.67 -30.15 33.51 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -73.57 -39.19 64.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.294 0.547 . . . . 0.0 110.796 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.19 -34.52 73.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -69.7 -29.32 66.71 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 119.771 -0.157 . . . . 0.0 110.761 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 44' ' ' ARG . 21.3 mmt180 -84.53 -34.22 23.33 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.42 -22.38 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 118.661 0.664 . . . . 0.0 111.361 175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -72.04 -17.38 62.03 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.204 -0.31 . . . . 0.0 111.496 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -70.6 -20.52 62.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.825 0.284 . . . . 0.0 111.742 175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 67.39 -175.99 24.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.89 0.41 59.87 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.934 -0.466 . . . . 0.0 111.934 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.1 mt -86.22 143.57 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 117.423 0.611 . . . . 0.0 109.852 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -99.29 -25.33 14.53 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.81 0.444 . . . . 0.0 111.607 -175.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.0 172.0 10.59 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.028 0.531 . . . . 0.0 110.057 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.61 169.02 19.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.593 0.235 . . . . 0.0 111.165 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -131.87 143.48 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.6 tp -143.13 122.62 13.18 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -76.35 146.96 38.43 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -58.59 -33.73 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.422 0.289 . . . . 0.0 110.897 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -126.56 134.91 50.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.69 0.396 . . . . 0.0 109.968 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -102.15 -168.42 1.54 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.538 0.735 . . . . 0.0 109.145 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -49.99 139.66 13.51 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.799 0.439 . . . . 0.0 110.344 -177.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.14 -2.82 87.28 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.95 5.57 84.76 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-N 117.422 0.611 . . . . 0.0 112.14 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -78.24 142.37 37.92 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.828 0.814 . . . . 0.0 111.087 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -69.55 142.4 53.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 123.391 0.677 . . . . 0.0 109.981 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -145.35 131.42 19.34 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.5 p -136.59 11.83 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 66' ' ' THR . 58.4 Cg_endo -67.94 -22.87 41.51 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 121.682 1.588 . . . . 0.0 110.317 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.413 ' O ' HD23 ' A' ' 72' ' ' LEU . 1.3 m -87.75 -40.07 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -66.22 -26.18 67.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -77.16 -26.52 53.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.658 0.383 . . . . 0.0 110.115 174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.86 -34.73 39.02 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 122.287 0.235 . . . . 0.0 110.622 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -68.28 -36.06 78.79 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -28.87 63.8 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 122.176 0.19 . . . . 0.0 110.795 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.88 -24.82 59.78 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.561 0.164 . . . . 0.0 110.638 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.2 mtt-85 -94.17 2.24 55.97 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.074 0.55 . . . . 0.0 110.855 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 58.62 17.58 5.15 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.167 0.987 . . . . 0.0 110.862 -176.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 41.1 mt -81.54 138.34 47.78 Favored Pre-proline 0 CA--C 1.531 0.25 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.9 Cg_exo -65.4 155.97 65.87 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.497 2.798 . . . . 0.0 112.152 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.48 142.7 23.27 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.18 153.51 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -101.85 161.93 13.29 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -130.99 143.03 50.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.133 -0.354 . . . . 0.0 110.116 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.3 p -143.27 177.52 8.36 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.83 -158.53 7.67 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.8 -3.36 54.99 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 95.9 p -147.74 169.45 19.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.358 1.063 . . . . 0.0 108.482 176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 56.68 15.39 2.14 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.5 p30 -72.24 7.43 1.73 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.7 t -78.18 55.61 1.54 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.11 0.564 . . . . 0.0 109.875 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 p -58.7 146.13 9.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -62.32 134.94 57.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.7 p -65.03 -14.6 60.85 Favored 'General case' 0 C--N 1.338 0.066 0 C-N-CA 122.544 0.338 . . . . 0.0 110.492 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.2 ttt85 -68.04 -13.87 62.53 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.191 0.596 . . . . 0.0 110.674 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -135.2 10.81 3.54 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 67.6 mtp85 -68.24 -9.57 48.28 Favored 'General case' 0 N--CA 1.461 0.109 0 O-C-N 121.806 -0.559 . . . . 0.0 111.564 178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.5 p30 -85.64 -6.41 59.15 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 173.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 -96.79 156.74 36.19 Favored Pre-proline 0 CA--C 1.527 0.079 0 C-N-CA 123.512 0.725 . . . . 0.0 109.251 176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -67.59 156.82 64.53 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.972 2.448 . . . . 0.0 110.424 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -149.6 128.5 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-O 121.288 0.566 . . . . 0.0 109.968 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.56 154.93 20.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 39.7 tt0 -139.43 -123.49 0.12 Allowed 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.199 -0.313 . . . . 0.0 110.26 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.435 ' H ' ' HG2' ' A' ' 101' ' ' GLN . 0.0 OUTLIER -56.07 165.47 1.41 Allowed Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.076 0.951 . . . . 0.0 110.175 176.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.9 Cg_exo -46.1 134.31 14.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.785 2.323 . . . . 0.0 111.254 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -124.2 153.51 41.49 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -77.92 174.13 11.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.48 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -62.09 -27.57 69.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -83.1 -20.95 33.9 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.51 58.79 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.05 -29.49 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 CA-C-N 117.121 0.461 . . . . 0.0 110.609 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.54 -25.01 63.81 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -73.96 -40.25 63.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 122.836 0.454 . . . . 0.0 110.225 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.93 -38.79 64.16 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.166 0.186 . . . . 0.0 110.862 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.4 mt -69.6 -25.18 63.83 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.72 -23.59 39.39 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.35 -14.17 59.15 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 122.591 0.356 . . . . 0.0 111.078 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.3 -13.28 48.94 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.975 -0.453 . . . . 0.0 110.707 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -92.48 0.5 57.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.696 0.399 . . . . 0.0 110.615 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 116.839 -1.553 . . . . 0.0 112.982 -177.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.5 t -70.42 151.82 44.75 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.611 0.364 . . . . 0.0 111.026 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.65 4.09 17.11 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.582 0.353 . . . . 0.0 111.551 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 21.1 tp -149.42 103.17 3.26 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.447 0.299 . . . . 0.0 110.264 -178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 p -140.99 -32.97 0.54 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -80.96 106.95 13.36 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.7 mt -129.25 131.73 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 O-C-N 122.463 -0.148 . . . . 0.0 111.02 -176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.7 tp -91.85 152.24 20.19 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 172.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.61 141.76 41.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.3 t -137.37 114.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -163.5 138.88 6.46 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.575 0.75 . . . . 0.0 109.257 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -83.97 -26.86 28.89 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -75.77 130.21 79.42 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -67.73 -39.1 12.33 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.321 2.014 . . . . 0.0 111.323 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mp -63.93 -42.22 97.43 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.825 0.078 . . . . 0.0 110.866 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -74.19 -32.5 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.85 -45.36 61.65 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 122.281 -0.262 . . . . 0.0 111.051 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.3 ptp -73.44 -26.27 60.86 Favored 'General case' 0 C--N 1.339 0.147 0 O-C-N 122.109 -0.369 . . . . 0.0 110.656 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 88.5 mmm -74.22 -32.59 63.08 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.93 -31.4 63.04 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.42 -32.52 71.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.788 0.267 . . . . 0.0 110.361 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -75.13 -40.3 59.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.537 0.208 . . . . 0.0 110.658 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.53 -27.32 65.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.0 mt -74.47 -39.21 62.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -67.46 -35.1 78.53 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.326 -0.234 . . . . 0.0 111.388 -176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.92 -25.04 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.7 mt -84.67 13.04 6.12 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.605 0.362 . . . . 0.0 110.449 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.8 t0 58.17 34.2 23.91 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.531 0.733 . . . . 0.0 110.567 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -108.39 -175.96 2.92 Favored 'General case' 0 C--O 1.23 0.06 0 C-N-CA 123.439 0.696 . . . . 0.0 109.255 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -132.98 116.89 14.69 Favored Pre-proline 0 CA--C 1.53 0.186 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -174.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -75.84 97.57 1.12 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.057 2.504 . . . . 0.0 108.56 169.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -81.09 -2.11 5.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -173.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.58 163.34 14.3 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 176.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.5 m -143.13 135.56 27.36 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.505 0.722 . . . . 0.0 111.737 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.29 166.08 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 122.75 0.42 . . . . 0.0 111.562 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -131.13 5.94 4.52 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.2 p -129.24 148.21 51.15 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.382 0.673 . . . . 0.0 111.1 171.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -73.45 -24.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 174.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -30.42 43.2 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.51 -34.19 62.98 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.089 0.444 . . . . 0.0 109.951 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.0 mt -70.15 -33.18 71.47 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.58 -28.66 59.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.89 -0.141 . . . . 0.0 110.948 -179.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -84.35 -34.26 23.69 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.17 -23.46 20.02 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.964 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -72.51 -20.53 61.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.086 0.154 . . . . 0.0 110.964 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -67.06 -21.25 65.91 Favored 'General case' 0 C--O 1.232 0.158 0 O-C-N 122.045 -0.41 . . . . 0.0 111.608 176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.32 -176.64 26.76 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 123.084 0.373 . . . . 0.0 112.177 176.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.23 1.99 71.39 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -90.16 143.07 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 CA-C-N 117.151 0.476 . . . . 0.0 110.136 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -96.52 -31.35 12.83 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.405 0.282 . . . . 0.0 111.517 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 175.36 10.85 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.142 0.577 . . . . 0.0 109.986 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.5 167.15 27.07 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 122.118 -0.364 . . . . 0.0 111.764 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 17.7 mt -125.9 143.33 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.673 0.789 . . . . 0.0 108.99 176.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.5 tp -148.16 124.67 11.02 Favored 'General case' 0 N--CA 1.461 0.078 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.05 149.45 37.51 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.28 -31.49 54.09 Favored 'Isoleucine or valine' 0 C--O 1.23 0.04 0 C-N-CA 122.08 0.152 . . . . 0.0 111.102 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -134.32 119.53 18.79 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.8 mp -88.13 -171.32 3.33 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -52.08 145.29 10.63 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-O 120.854 0.359 . . . . 0.0 111.073 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.94 -6.42 74.9 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.99 6.55 68.24 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 123.338 0.494 . . . . 0.0 112.391 177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -76.02 145.73 39.99 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.694 0.747 . . . . 0.0 110.732 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.69 146.84 52.62 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 122.881 0.472 . . . . 0.0 110.195 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.8 m -142.28 116.86 9.71 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.251 0.22 . . . . 0.0 110.613 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.3 p -136.87 6.13 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 116.553 2.057 . . . . 0.0 116.553 173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.1 Cg_endo -68.58 -24.03 36.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.99 1.794 . . . . 0.0 110.728 -173.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.4 m -88.07 -28.43 5.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.65 -30.14 64.04 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -76.95 -27.55 54.87 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.313 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.92 -32.73 57.57 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.2 -33.97 75.41 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.89 -29.19 64.09 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.124 0.17 . . . . 0.0 110.857 177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.01 -30.99 34.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.402 0.281 . . . . 0.0 110.674 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtt-85 -87.21 4.64 41.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.558 0.743 . . . . 0.0 111.379 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.4 t0 54.5 45.89 26.06 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.787 0.835 . . . . 0.0 111.524 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.3 pt -127.08 139.29 34.68 Favored Pre-proline 0 CA--C 1.534 0.328 0 C-N-CA 122.745 0.418 . . . . 0.0 109.967 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -65.04 156.69 61.3 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 123.591 2.861 . . . . 0.0 112.38 -177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -146.52 142.61 28.22 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.39 150.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 176.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -102.71 160.34 14.68 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.03 139.13 52.19 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 76.7 p -138.69 177.32 7.97 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.19 -154.07 6.59 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.06 -8.69 74.67 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.571 -0.572 . . . . 0.0 112.23 -177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -142.37 -17.04 0.73 Allowed 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 117.532 0.666 . . . . 0.0 111.386 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -85.11 3.61 38.1 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.5 p30 -74.33 6.18 3.87 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 27.6 t -80.38 36.26 0.36 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.512 0.725 . . . . 0.0 110.11 175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.92 143.71 11.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 C-N-CA 122.941 0.497 . . . . 0.0 109.838 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -72.54 146.6 46.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -174.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.6 p -66.78 -11.61 55.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 122.389 0.276 . . . . 0.0 111.226 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -71.56 -6.78 43.26 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.814 0.445 . . . . 0.0 110.901 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.4 5.34 2.96 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 117.725 0.239 . . . . 0.0 110.766 -176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -73.11 -6.63 46.95 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.987 -0.446 . . . . 0.0 111.242 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -85.85 6.83 26.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.517 0.727 . . . . 0.0 111.802 172.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.65 160.87 64.22 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 124.237 1.015 . . . . 0.0 109.791 -177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.27 159.24 53.7 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.94 2.427 . . . . 0.0 110.539 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.71 127.11 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.252 0.549 . . . . 0.0 109.744 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.1 mt -85.74 153.45 22.31 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -139.49 -117.61 0.13 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -174.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 165.59 1.32 Allowed Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 123.802 0.841 . . . . 0.0 110.42 174.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -47.78 142.99 13.6 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.917 2.411 . . . . 0.0 111.36 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.68 152.62 49.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 p -84.43 176.36 8.72 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.499 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -61.13 -29.46 69.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -82.63 -22.28 34.78 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.79 -37.85 50.7 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -77.76 -27.46 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 CA-C-N 117.256 0.528 . . . . 0.0 110.467 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.58 -28.08 62.59 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -70.04 -38.67 75.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.04 0.536 . . . . 0.0 110.481 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.28 69.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.768 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -72.38 -29.06 63.42 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.27 63.1 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.51 -10.11 56.48 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.96 0.504 . . . . 0.0 111.036 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 36.2 tp -75.97 -25.06 55.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.59 0.356 . . . . 0.0 111.869 -177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.0 mp -93.13 -0.01 57.1 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.482 0.313 . . . . 0.0 111.701 -176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.251 1.151 0 CA-C-O 117.81 -1.09 . . . . 0.0 112.348 -179.154 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 tpp . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 120.516 0.198 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.8 m -77.82 -7.45 56.65 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.719 0.408 . . . . 0.0 111.725 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.81 9.4 3.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.701 0.4 . . . . 0.0 111.447 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.5 tp -149.46 117.36 6.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.829 0.452 . . . . 0.0 109.818 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.13 -51.67 0.14 Allowed 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -74.45 116.92 15.68 Favored 'General case' 0 N--CA 1.458 -0.074 0 CA-C-N 118.26 0.482 . . . . 0.0 110.183 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -130.55 135.11 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.655 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 tp -98.41 153.06 18.85 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 174.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 24.5 mt -125.81 141.66 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.1 100.15 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-O 120.571 0.224 . . . . 0.0 110.921 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -165.67 -179.28 5.28 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.862 0.465 . . . . 0.0 109.813 -177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -129.04 -10.1 4.81 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -76.87 134.05 69.01 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.92 -42.92 2.84 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.758 2.305 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -63.07 -40.1 96.68 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 122.202 0.201 . . . . 0.0 111.333 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mm -76.7 -27.29 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.95 -42.18 60.9 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 122.4 -0.187 . . . . 0.0 110.673 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.8 ptp -72.66 -25.52 61.3 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 122.286 -0.259 . . . . 0.0 110.517 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.36 -44.53 58.51 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 175.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 76.8 mt -71.4 -26.68 62.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 117.521 0.146 . . . . 0.0 111.054 -177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -70.23 -35.55 73.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.907 0.322 . . . . 0.0 110.253 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -75.81 -41.54 52.41 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.372 0.269 . . . . 0.0 110.915 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -71.89 -30.49 65.44 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -77.13 -36.74 55.14 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.8 tp10 -70.41 -35.22 73.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 122.492 -0.13 . . . . 0.0 111.183 -177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.3 p -75.83 -24.5 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 117.813 0.279 . . . . 0.0 111.6 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.93 12.77 5.68 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.583 0.353 . . . . 0.0 110.474 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 58.33 22.99 9.98 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.75 -176.0 4.33 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.9 m -131.72 108.33 14.32 Favored Pre-proline 0 C--N 1.333 -0.11 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 61.4 Cg_endo -74.52 93.68 0.92 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.68 2.253 . . . . 0.0 108.733 170.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -75.78 -8.54 11.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -175.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.88 169.85 25.79 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.463 -0.399 . . . . 0.0 112.299 176.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.9 m -144.34 140.33 29.05 Favored 'General case' 0 CA--C 1.521 -0.147 0 C-N-CA 123.69 0.796 . . . . 0.0 109.15 177.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.24 164.17 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 C-N-CA 122.487 0.315 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -123.85 4.64 8.76 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.1 p -137.47 156.48 48.11 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 123.066 0.546 . . . . 0.0 111.807 176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 m -70.79 -24.91 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.96 -36.27 79.78 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.96 -28.77 49.15 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.89 -37.78 62.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.13 0.465 . . . . 0.0 110.894 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 67.7 mt -70.51 -32.36 69.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.53 -33.25 62.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.94 -0.118 . . . . 0.0 110.995 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -81.49 -34.6 31.21 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -74.42 -22.61 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 118.482 0.583 . . . . 0.0 111.212 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -74.52 -22.12 59.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.491 0.316 . . . . 0.0 110.968 176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -66.76 -17.55 64.93 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -174.99 31.15 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 111.885 -0.486 . . . . 0.0 111.885 176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.87 -6.75 31.75 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.812 -0.515 . . . . 0.0 111.812 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.87 143.65 11.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-N 117.36 0.58 . . . . 0.0 109.885 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -109.46 -14.32 14.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.5 168.95 14.29 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.283 0.633 . . . . 0.0 109.475 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.58 167.99 23.96 Favored 'General case' 0 C--O 1.232 0.152 0 O-C-N 122.31 -0.244 . . . . 0.0 111.028 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.25 143.58 39.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 tp -140.91 123.96 16.41 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -77.12 139.31 39.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.4 t -62.59 -29.17 46.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 122.476 0.31 . . . . 0.0 110.611 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -130.58 118.7 21.42 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.79 -169.67 2.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -53.5 143.66 19.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 120.705 0.288 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.44 -6.96 78.28 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.03 3.1 63.58 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.36 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -72.28 146.55 47.13 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 117.832 0.816 . . . . 0.0 110.378 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -63.56 157.28 24.12 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.0 m -143.78 112.29 6.46 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.972 0.415 . . . . 0.0 111.623 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.603 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.9 p -132.29 8.26 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 169.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 66' ' ' THR . 56.0 Cg_endo -68.59 -27.36 32.73 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.614 1.543 . . . . 0.0 110.294 -173.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' HD23 ' A' ' 72' ' ' LEU . 3.1 m -91.14 -35.14 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.0 -28.76 70.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 118.435 0.561 . . . . 0.0 110.31 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -77.16 -27.09 53.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.301 174.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.03 -33.44 39.14 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.775 0.43 . . . . 0.0 110.83 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -67.06 -36.77 82.77 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.21 -27.76 63.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 121.969 0.107 . . . . 0.0 110.889 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.27 -28.6 59.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.7 mtt-85 -90.16 2.53 55.23 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.182 0.593 . . . . 0.0 110.842 177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.4 t0 58.39 20.13 7.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.236 1.014 . . . . 0.0 111.115 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.01 136.71 35.92 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 24.7 Cg_exo -61.26 154.95 54.53 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.665 2.91 . . . . 0.0 112.014 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -150.18 146.21 26.72 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.57 151.91 18.34 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -100.34 157.95 16.24 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.27 137.77 54.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 44.3 p -142.86 177.65 8.2 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 122.605 0.362 . . . . 0.0 111.118 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -148.17 -153.29 5.92 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.36 -10.42 78.83 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.333 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.2 m -144.97 -13.61 0.54 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.493 0.647 . . . . 0.0 111.551 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -84.42 5.48 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -79.44 15.02 1.37 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.121 0.568 . . . . 0.0 112.317 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.9 p -79.4 29.32 0.24 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.506 0.722 . . . . 0.0 111.396 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.3 p -60.24 141.93 16.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -73.31 158.5 34.98 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.456 0.703 . . . . 0.0 110.007 -171.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.401 ' HA ' ' CG ' ' A' ' 95' ' ' ARG . 97.5 p -65.15 -16.81 63.91 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.049 0.54 . . . . 0.0 111.345 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.56 -4.93 33.68 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.687 0.395 . . . . 0.0 111.646 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -136.58 7.22 3.02 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' CG ' ' HA ' ' A' ' 92' ' ' SER . 14.8 mmt180 -67.94 -16.89 64.27 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.239 0.472 . . . . 0.0 110.847 175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -87.67 0.54 55.54 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.97 0.508 . . . . 0.0 112.174 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.407 ' HA ' ' NE ' ' A' ' 97' ' ' ARG . 4.6 mmp_? -108.02 154.91 40.87 Favored Pre-proline 0 CA--C 1.529 0.138 0 C-N-CA 123.473 0.709 . . . . 0.0 109.749 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.74 156.73 64.52 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.956 2.438 . . . . 0.0 110.409 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.31 127.92 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.248 0.547 . . . . 0.0 110.177 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.9 mt -87.01 151.45 23.25 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 169.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -139.37 -115.15 0.14 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -174.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.95 165.27 1.84 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.338 0.655 . . . . 0.0 109.924 174.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -48.45 141.19 19.88 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 122.885 2.39 . . . . 0.0 111.253 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -129.03 159.24 36.54 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -99.41 -178.56 3.94 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.0 tpp -59.03 -30.45 68.03 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -74.45 -21.93 59.36 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 111.587 0.218 . . . . 0.0 111.587 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.45 -38.83 10.35 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 m -75.96 -31.52 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-N 117.593 0.696 . . . . 0.0 110.895 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.89 -24.79 63.46 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -72.61 -42.53 64.37 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.718 0.407 . . . . 0.0 110.519 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.04 -44.41 54.43 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.206 0.202 . . . . 0.0 110.854 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 98.1 mt -69.82 -25.17 63.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.378 -0.201 . . . . 0.0 110.746 -176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.3 -26.74 42.21 Favored 'General case' 0 N--CA 1.454 -0.264 0 O-C-N 122.276 -0.265 . . . . 0.0 110.321 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -14.61 60.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.364 -0.21 . . . . 0.0 110.96 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.2 -11.9 52.66 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.955 -0.466 . . . . 0.0 110.842 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.86 3.83 49.76 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.648 0.379 . . . . 0.0 110.843 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 117.001 -1.476 . . . . 0.0 113.037 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.47 -0.196 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.6 t -65.86 151.45 46.66 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 122.605 0.362 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.93 -0.58 31.48 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.628 0.371 . . . . 0.0 111.584 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.94 115.78 4.55 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 122.413 0.285 . . . . 0.0 110.337 -179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 p -147.34 -33.9 0.26 Allowed 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 38.1 mm-40 -77.84 110.38 12.67 Favored 'General case' 0 C--O 1.23 0.073 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.7 mt -130.39 137.77 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 tp -100.48 153.1 19.63 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 66.6 mt -124.11 143.2 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.74 105.73 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.096 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -157.51 150.66 23.49 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -109.76 -25.81 10.17 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 41.2 tp10 -69.92 133.67 88.08 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 35.0 Cg_exo -61.44 -42.15 35.93 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.432 2.088 . . . . 0.0 111.786 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -69.58 -50.75 41.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.622 0.369 . . . . 0.0 111.383 -174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.5 mm -66.96 -26.87 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 122.152 -0.343 . . . . 0.0 110.11 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.43 -46.08 50.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 122.305 -0.247 . . . . 0.0 110.532 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.0 ptp -74.24 -26.85 60.48 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.117 -0.364 . . . . 0.0 110.883 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 92.1 mmm -72.08 -34.07 68.39 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 122.353 -0.217 . . . . 0.0 110.76 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.8 mt -73.12 -32.34 64.87 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.86 -30.57 67.0 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -75.26 -40.43 58.86 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.603 0.24 . . . . 0.0 110.541 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -70.12 -28.22 65.2 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.35 -37.37 60.71 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.952 -0.468 . . . . 0.0 110.056 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.59 -25.0 56.63 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.647 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 p -81.2 -23.69 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.0 mt -85.2 13.82 5.91 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.493 0.317 . . . . 0.0 110.449 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 57.9 22.28 8.53 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 -176.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -91.5 -173.01 3.43 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 174.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.4 m -134.81 107.46 10.67 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -72.92 101.61 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.6 2.2 . . . . 0.0 108.843 170.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.3 m -80.53 -5.17 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -174.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.63 167.69 22.44 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.182 -0.533 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 11.9 m -140.88 140.68 34.6 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.649 0.78 . . . . 0.0 111.08 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.98 159.51 39.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 122.335 0.254 . . . . 0.0 111.45 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -124.69 5.52 8.17 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 p -132.39 152.04 51.62 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.358 0.663 . . . . 0.0 111.581 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.57 -25.51 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.06 -27.47 63.66 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.94 -30.55 38.18 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.21 -35.22 68.83 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.198 0.499 . . . . 0.0 110.331 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.5 mt -72.09 -33.71 68.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.67 -27.74 58.44 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.21 0.078 . . . . 0.0 111.21 -178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -79.19 -42.5 25.91 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.0 p -73.28 -23.6 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.944 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -71.84 -21.14 61.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.512 0.325 . . . . 0.0 110.881 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -70.98 -24.32 62.38 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.09 -173.44 38.99 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 177.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.51 -1.38 66.43 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 91.4 mt -86.15 142.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 117.281 0.54 . . . . 0.0 109.889 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -95.89 -25.8 15.86 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 122.679 0.391 . . . . 0.0 111.981 -176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.28 170.18 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.058 0.543 . . . . 0.0 109.742 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 162.52 38.91 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.269 -0.269 . . . . 0.0 111.292 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 24.2 mt -120.75 143.56 32.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.9 tp -140.96 124.61 16.89 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -170.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -78.19 138.89 38.9 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 172.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.6 t -62.43 -26.66 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 122.571 0.349 . . . . 0.0 110.921 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.19 118.8 8.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.918 0.389 . . . . 0.0 110.878 178.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.14 -173.22 4.6 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -50.97 143.36 10.38 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.074 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.8 -7.73 68.81 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.91 7.15 65.49 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 117.29 0.545 . . . . 0.0 112.082 177.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -68.82 150.48 47.77 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.466 0.633 . . . . 0.0 110.632 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.46 143.01 47.02 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.546 ' C ' ' HD2' ' A' ' 67' ' ' PRO . 70.6 m -138.26 41.13 2.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.541 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.6 p -96.92 7.64 0.06 OUTLIER Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 116.917 2.192 . . . . 0.0 116.917 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.546 ' HD2' ' C ' ' A' ' 65' ' ' SER . 59.9 Cg_endo -69.73 -19.41 36.29 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 121.534 1.584 . . . . 0.0 109.384 -177.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.8 m -89.63 -38.32 10.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.377 0 CA-C-O 119.39 -0.338 . . . . 0.0 111.454 176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -29.87 71.1 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.514 0.597 . . . . 0.0 109.877 -177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -76.06 -29.23 57.93 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.843 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.83 -34.64 33.71 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 122.752 0.421 . . . . 0.0 111.088 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.4 mm? -66.44 -35.79 81.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.17 -29.7 64.27 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 110.555 -0.165 . . . . 0.0 110.555 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.76 -27.68 60.44 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 117.539 0.154 . . . . 0.0 110.844 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -90.69 3.24 54.79 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.058 0.543 . . . . 0.0 110.678 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.6 t0 58.24 20.87 7.56 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.252 1.021 . . . . 0.0 111.496 -177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 28.2 mt -86.65 136.27 35.01 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 18.4 Cg_exo -63.9 151.67 84.18 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.252 2.635 . . . . 0.0 111.531 176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -144.52 142.36 30.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.68 150.59 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -102.39 154.59 18.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 171.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.69 131.21 52.63 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.2 p -138.82 177.32 7.97 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.04 -159.29 9.1 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -72.11 -4.25 58.92 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 119.87 -0.405 . . . . 0.0 112.404 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 89.3 p -149.73 -12.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 117.657 0.728 . . . . 0.0 111.532 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.16 7.45 24.89 Favored 'General case' 0 C--N 1.338 0.108 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -74.58 12.56 0.77 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.4 t -79.13 31.55 0.21 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.542 0.737 . . . . 0.0 111.113 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.7 p -58.08 147.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -58.33 135.25 57.14 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.964 0.506 . . . . 0.0 110.475 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.0 m -64.56 -15.89 61.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.787 0.435 . . . . 0.0 111.34 -178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.5 ttt-85 -71.24 -14.34 62.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.366 0.266 . . . . 0.0 110.609 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -124.1 9.17 8.65 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 122.637 0.375 . . . . 0.0 111.193 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -66.74 -13.98 62.02 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.723 0.238 . . . . 0.0 110.966 177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -77.55 -21.19 52.93 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.352 0.261 . . . . 0.0 111.556 175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -83.07 157.61 65.75 Favored Pre-proline 0 C--O 1.232 0.137 0 C-N-CA 123.201 0.6 . . . . 0.0 109.745 175.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.88 159.89 51.66 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.716 2.277 . . . . 0.0 109.907 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -147.82 126.48 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 121.379 0.609 . . . . 0.0 109.56 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -87.37 154.53 20.6 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -139.47 -123.65 0.12 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -172.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.85 165.65 0.92 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 123.528 0.731 . . . . 0.0 110.257 173.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 72.2 Cg_exo -46.45 140.61 11.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.929 2.419 . . . . 0.0 111.535 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.49 152.42 48.28 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.4 p -78.43 172.27 13.88 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -29.21 70.39 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -83.15 -23.39 32.97 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -70.66 -39.22 67.24 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.386 -0.686 . . . . 0.0 111.386 -176.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -76.39 -28.89 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.475 0.637 . . . . 0.0 110.448 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.9 -25.43 62.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -73.25 -38.38 65.99 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.672 0.389 . . . . 0.0 110.223 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.89 -40.99 62.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.943 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.5 mt -72.17 -22.41 61.29 Favored 'General case' 0 CA--C 1.529 0.16 0 O-C-N 122.348 -0.22 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.18 -34.03 56.35 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.963 0.347 . . . . 0.0 110.103 176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.39 -8.14 59.63 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.999 0.52 . . . . 0.0 111.076 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 35.4 tp -74.58 -23.92 58.83 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 122.489 0.316 . . . . 0.0 111.841 -178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.65 -3.51 58.21 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.595 0.358 . . . . 0.0 111.642 -176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.3 m . . . . . 0 C--O 1.25 1.11 0 CA-C-O 116.879 -1.534 . . . . 0.0 112.458 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 tpt . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.624 -0.139 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.9 t -155.69 157.53 36.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.825 0.45 . . . . 0.0 110.315 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.96 8.13 21.64 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.843 0.457 . . . . 0.0 111.213 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -140.27 78.53 1.66 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.179 0.591 . . . . 0.0 109.695 -177.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 p -134.47 -34.87 0.92 Allowed 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.16 109.58 15.84 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.411 HD11 ' CD1' ' A' ' 4' ' ' LEU . 34.8 mt -129.35 134.31 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 O-C-N 122.279 -0.263 . . . . 0.0 111.452 -175.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 tp -100.08 153.21 19.41 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.085 0.554 . . . . 0.0 109.907 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.3 mt -127.11 142.71 42.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 t -136.52 100.21 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.475 0.179 . . . . 0.0 110.802 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -165.11 169.58 16.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.945 0.498 . . . . 0.0 109.673 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -112.44 -11.44 13.64 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 34.3 tp10 -77.71 132.65 67.9 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 5.4 Cg_exo -71.46 -38.86 4.14 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.424 2.083 . . . . 0.0 111.784 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 15' ' ' LEU . 7.6 mp -67.29 -42.96 82.9 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.656 0.383 . . . . 0.0 110.905 -171.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.3 mm -72.85 -28.24 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.29 58.96 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.794 -0.076 . . . . 0.0 110.794 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -70.61 -25.63 63.13 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.549 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.2 mmm -74.68 -34.36 62.65 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 110.526 -0.175 . . . . 0.0 110.526 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.8 mt -75.82 -27.49 57.92 Favored 'General case' 0 C--O 1.226 -0.151 0 O-C-N 122.369 -0.207 . . . . 0.0 110.712 178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.98 -32.68 71.01 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.508 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -75.25 -43.54 50.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.753 0.311 . . . . 0.0 110.763 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -68.95 -31.15 69.82 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.9 -33.89 57.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -74.42 -35.17 63.39 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.387 -0.196 . . . . 0.0 111.426 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.7 p -74.16 -25.81 20.24 Favored 'Isoleucine or valine' 0 C--N 1.339 0.131 0 O-C-N 122.167 -0.333 . . . . 0.0 111.461 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 95.2 mt -82.1 10.59 6.42 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.497 0.319 . . . . 0.0 110.598 173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 40.2 t0 57.71 30.27 18.65 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.689 0.796 . . . . 0.0 111.189 -178.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -100.27 -174.42 2.66 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.1 m -132.29 109.38 13.73 Favored Pre-proline 0 CA--C 1.53 0.208 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.92 95.13 0.96 Allowed 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.81 2.34 . . . . 0.0 108.788 169.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -77.28 -8.06 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -174.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.36 167.92 22.51 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.086 175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.5 m -142.77 141.41 31.71 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.543 0.737 . . . . 0.0 109.782 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 m -135.95 159.45 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 C-N-CA 122.694 0.398 . . . . 0.0 111.242 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -117.86 3.53 12.22 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -137.29 155.92 48.88 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.32 0.648 . . . . 0.0 112.214 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 m -70.56 -24.72 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.82 -35.22 78.22 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.3 -29.58 40.17 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.04 -37.05 61.82 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 117.096 0.448 . . . . 0.0 110.928 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.7 mt -71.19 -31.76 68.03 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.03 -28.44 61.43 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.029 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -79.72 -44.41 20.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -74.59 -22.92 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -71.98 -26.82 62.4 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.384 -0.198 . . . . 0.0 110.933 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -71.08 -16.61 62.59 Favored 'General case' 0 CA--C 1.527 0.092 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.67 -168.34 43.4 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.41 -4.73 48.21 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.9 mt -89.18 141.93 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -96.78 -25.71 15.4 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.21 168.23 17.27 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.38 167.76 23.54 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 122.068 -0.395 . . . . 0.0 111.452 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.46 143.56 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.474 0.71 . . . . 0.0 109.269 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 tp -139.53 124.92 19.1 Favored 'General case' 0 C--O 1.226 -0.147 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -79.42 140.13 37.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.82 -29.31 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 O-C-N 122.302 -0.249 . . . . 0.0 110.429 -178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -128.29 118.71 23.74 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.99 -168.4 2.2 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -55.54 141.52 36.84 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.347 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 85.75 -5.39 83.86 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.29 6.19 79.32 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 123.367 0.508 . . . . 0.0 112.801 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -75.13 142.5 43.59 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 117.679 0.74 . . . . 0.0 110.834 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -64.62 141.74 58.67 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.418 0.687 . . . . 0.0 110.475 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -147.94 128.27 13.91 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-O 120.802 0.334 . . . . 0.0 111.703 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.586 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 3.7 p -139.4 14.75 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 169.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 66' ' ' THR . 47.4 Cg_endo -66.01 -23.89 53.38 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.771 1.647 . . . . 0.0 110.798 -172.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.408 ' O ' HD23 ' A' ' 72' ' ' LEU . 5.1 m -90.39 -35.92 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.5 -27.77 69.2 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.558 0.617 . . . . 0.0 109.979 -178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -73.32 -30.75 63.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.75 -33.39 31.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 122.544 0.337 . . . . 0.0 111.003 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.3 mm? -65.45 -36.31 83.53 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.04 65.02 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.425 0.29 . . . . 0.0 110.818 178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.56 -27.65 60.59 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.417 0.151 . . . . 0.0 110.923 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt-85 -90.76 2.73 55.77 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.059 0.543 . . . . 0.0 110.726 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.8 t0 58.04 21.48 7.88 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.211 1.004 . . . . 0.0 111.34 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 27.0 mt -85.95 139.08 34.81 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.5 Cg_exo -63.11 152.87 77.35 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.326 2.684 . . . . 0.0 111.72 176.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -149.16 145.55 27.23 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.55 150.33 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -97.7 161.51 13.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -128.59 139.91 52.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 48.3 p -142.33 177.48 8.23 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 -175.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -149.83 -155.81 6.97 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.13 -12.39 79.46 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.8 m -142.94 -13.56 0.73 Allowed 'General case' 0 CA--C 1.526 0.052 0 CA-C-N 117.101 0.451 . . . . 0.0 111.192 178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.46 3.92 34.07 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -78.75 15.67 1.01 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 t -80.98 33.24 0.33 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.409 0.684 . . . . 0.0 110.597 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.44 148.3 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 121.136 0.493 . . . . 0.0 110.122 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -67.63 141.35 56.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.6 p -64.47 -17.74 64.12 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.033 0.133 . . . . 0.0 110.905 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -70.86 -11.97 61.27 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.844 0.458 . . . . 0.0 111.177 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -122.37 3.67 9.71 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -72.19 -10.63 60.04 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.155 -0.341 . . . . 0.0 110.444 175.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -86.58 9.47 18.4 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.208 0.603 . . . . 0.0 111.365 171.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.6 mmt-85 -121.13 155.61 57.99 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 123.931 0.892 . . . . 0.0 109.087 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.32 151.6 84.72 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.948 2.432 . . . . 0.0 110.719 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 p -150.73 126.96 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 121.024 0.44 . . . . 0.0 109.993 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.2 mt -86.12 153.21 22.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 169.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.36 -119.81 0.13 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 165.17 1.29 Allowed Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.66 0.784 . . . . 0.0 110.281 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.45 135.38 20.67 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.629 2.219 . . . . 0.0 110.944 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.19 154.41 37.51 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 -169.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 p -81.46 176.18 9.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.46 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.64 -28.52 69.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -83.13 -20.96 33.81 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.97 -38.84 59.8 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.9 m -76.03 -29.85 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 117.325 0.563 . . . . 0.0 110.613 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -25.24 63.54 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.35 -41.59 69.59 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.94 0.496 . . . . 0.0 110.628 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.69 -41.52 62.52 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.567 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.0 -27.93 66.14 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.25 -23.77 43.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.17 -14.6 59.4 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.374 -0.204 . . . . 0.0 111.029 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.83 -10.72 60.13 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 122.115 -0.366 . . . . 0.0 111.392 175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -95.55 -7.51 37.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 122.568 0.347 . . . . 0.0 111.421 -177.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.064 -1.446 . . . . 0.0 112.296 -178.582 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 mmt . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 120.216 0.055 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -73.9 172.28 11.88 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.737 0.415 . . . . 0.0 110.906 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.89 16.17 0.57 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.164 0.586 . . . . 0.0 111.651 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.45 106.77 7.66 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -140.78 -38.5 0.43 Allowed 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -79.46 108.79 13.25 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 35.7 mt -129.8 136.12 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.029 0.131 . . . . 0.0 111.23 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.0 tp -97.47 153.3 18.22 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.4 mt -125.07 141.2 45.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.1 t -138.2 116.28 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.626 0.37 . . . . 0.0 110.556 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -154.94 -178.31 7.14 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.323 0.649 . . . . 0.0 109.675 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -133.57 10.75 4.05 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.7 tp10 -117.28 133.94 23.14 Favored Pre-proline 0 C--N 1.342 0.243 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.21 -38.25 45.93 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.0 mt -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.415 0.286 . . . . 0.0 111.24 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -68.99 -24.9 28.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.63 -52.72 16.53 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.5 ptp -70.58 -25.2 62.96 Favored 'General case' 0 CA--C 1.526 0.051 0 O-C-N 122.627 -0.045 . . . . 0.0 111.041 -175.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.0 mmm -72.09 -36.52 69.52 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.1 mt -78.63 -31.3 46.89 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 122.559 -0.088 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.69 -31.2 70.13 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.576 0.171 . . . . 0.0 110.749 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -74.69 -43.04 57.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.448 0.166 . . . . 0.0 110.836 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -70.93 -27.51 63.82 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -176.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.4 mt -74.11 -40.96 62.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.88 -24.93 62.59 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -177.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 p -84.03 -22.35 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 77.2 mt -86.99 16.17 5.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.881 0.472 . . . . 0.0 111.037 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.8 t0 58.82 23.26 11.07 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.457 0.703 . . . . 0.0 111.428 -175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -99.55 -177.61 3.63 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 m -136.65 113.17 10.01 Favored Pre-proline 0 N--CA 1.453 -0.278 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -173.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.47 94.12 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.993 2.462 . . . . 0.0 108.797 169.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.1 m -78.84 0.62 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -174.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.35 165.34 17.99 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.8 m -142.76 136.04 28.49 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.551 0.74 . . . . 0.0 111.369 178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 m -139.6 165.53 22.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 122.592 0.357 . . . . 0.0 110.392 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -128.22 4.56 5.79 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.6 p -136.46 154.9 50.63 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.031 0.532 . . . . 0.0 111.712 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 m -69.35 -24.68 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.157 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -177.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.83 -35.22 78.2 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.6 -31.48 36.64 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.87 -36.95 62.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 116.983 0.391 . . . . 0.0 110.685 -179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 mt -69.8 -31.84 69.97 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.08 -34.17 63.9 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.837 0.055 . . . . 0.0 110.857 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -81.81 -31.79 31.6 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.2 p -77.09 -23.09 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 CA-C-N 118.223 0.465 . . . . 0.0 111.652 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.85 -21.95 59.94 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.291 0.236 . . . . 0.0 110.489 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -68.11 -15.6 63.66 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 68.89 -173.11 35.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.965 -0.454 . . . . 0.0 111.965 175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.05 -2.15 56.93 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.898 -0.481 . . . . 0.0 111.898 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 93.0 mt -91.0 143.19 11.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 117.218 0.509 . . . . 0.0 110.174 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.95 -32.38 12.06 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.67 0.388 . . . . 0.0 111.132 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 174.32 13.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.158 0.583 . . . . 0.0 109.643 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.41 166.34 28.4 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.982 -0.449 . . . . 0.0 111.324 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 18.1 mt -123.7 143.42 36.93 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.102 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.5 tp -144.11 121.88 11.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -75.06 140.04 43.24 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.5 -30.56 44.78 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.098 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -126.98 134.49 50.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.48 -173.99 2.44 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -51.62 144.15 11.23 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.245 0.545 . . . . 0.0 110.998 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.42 -5.27 81.58 Favored Glycine 0 CA--C 1.535 1.287 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.52 6.97 78.15 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-N 117.235 0.518 . . . . 0.0 112.45 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -76.25 140.13 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 117.699 0.749 . . . . 0.0 110.548 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -67.84 143.03 55.95 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 123.076 0.55 . . . . 0.0 110.226 179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -145.68 129.69 17.42 Favored 'General case' 0 C--O 1.23 0.071 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.588 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.0 p -139.69 15.14 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 171.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 66' ' ' THR . 53.7 Cg_endo -66.5 -27.42 46.47 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 121.98 1.787 . . . . 0.0 111.385 -171.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.6 m -88.99 -25.67 5.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.29 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.5 -28.21 62.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -74.64 -30.51 61.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.899 173.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.69 -31.93 52.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.249 0.22 . . . . 0.0 110.502 178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -31.95 70.42 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.16 -29.04 61.59 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.564 -0.161 . . . . 0.0 110.564 176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.05 -32.78 39.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.484 0.314 . . . . 0.0 110.784 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -85.9 1.61 49.25 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.394 0.677 . . . . 0.0 111.409 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t0 54.54 48.74 19.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.619 0.767 . . . . 0.0 111.334 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.35 142.63 43.42 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 122.848 0.459 . . . . 0.0 109.77 175.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 21.0 Cg_exo -64.81 155.42 67.61 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.152 2.568 . . . . 0.0 111.799 -177.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -145.38 142.24 29.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 84.6 t -111.8 144.16 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -96.24 157.07 16.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 170.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.37 143.64 51.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 175.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.1 p -141.6 177.59 8.04 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.81 -170.18 25.07 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -68.97 -7.57 56.52 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.789 -0.451 . . . . 0.0 112.333 -177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.7 m -140.14 9.11 2.3 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.486 0.643 . . . . 0.0 110.618 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -126.1 8.49 7.33 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.453 0.701 . . . . 0.0 112.528 -176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.1 p30 -77.03 15.2 0.72 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.1 m -77.11 35.3 0.16 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.444 0.697 . . . . 0.0 111.302 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.69 145.55 11.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.973 0.416 . . . . 0.0 110.186 -178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -71.77 133.71 45.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.0 p -68.11 -11.89 59.9 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.67 0.388 . . . . 0.0 111.033 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 93' ' ' ARG . 38.0 ttt-85 -75.21 -19.63 59.68 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 122.48 0.312 . . . . 0.0 110.858 175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -115.88 2.86 13.65 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -11.15 57.64 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.709 0.231 . . . . 0.0 111.12 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.23 -18.36 62.46 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.381 0.273 . . . . 0.0 111.222 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -93.31 159.45 35.24 Favored Pre-proline 0 N--CA 1.455 -0.212 0 C-N-CA 123.573 0.749 . . . . 0.0 109.307 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -71.06 160.45 49.2 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.982 2.455 . . . . 0.0 110.329 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 p -147.2 126.41 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 98.8 mt -87.68 154.15 20.81 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 102' ' ' LYS . 46.4 tt0 -139.39 -124.48 0.12 Allowed 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -54.99 165.64 0.94 Allowed Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.039 0.936 . . . . 0.0 110.174 173.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 76.0 Cg_exo -45.56 138.69 10.63 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.853 2.369 . . . . 0.0 111.537 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.8 151.96 48.38 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -169.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.5 p -77.23 171.72 14.39 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -31.7 71.21 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -82.02 -21.08 37.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.91 -37.18 56.95 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.1 m -78.35 -27.7 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 117.292 0.546 . . . . 0.0 110.636 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -73.32 -25.97 60.86 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -69.69 -38.49 77.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.865 0.466 . . . . 0.0 110.243 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.14 -42.52 65.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.849 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -70.92 -26.15 63.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.358 -0.214 . . . . 0.0 110.5 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.05 -32.19 61.48 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 117.958 0.345 . . . . 0.0 110.387 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -86.03 -8.03 58.22 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.927 0.491 . . . . 0.0 110.883 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 38.2 tp -73.51 -25.5 60.46 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.2 mp -88.26 -4.49 58.69 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 122.438 0.295 . . . . 0.0 111.427 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.38 -178.613 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.476 0.845 0 N-CA-C 110.705 -0.109 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.2 m -68.5 164.07 22.02 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.619 0.368 . . . . 0.0 110.835 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.43 4.1 7.99 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.571 0.348 . . . . 0.0 111.864 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.4 tp -150.47 107.24 3.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 p -143.32 -31.85 0.48 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -81.06 109.76 15.93 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.0 mt -129.81 137.19 57.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 117.639 0.2 . . . . 0.0 111.056 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.4 tp -99.39 152.49 19.91 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 52.1 mt -122.08 140.55 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.48 104.0 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -156.49 140.1 15.95 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -171.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -92.26 -26.14 18.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -75.99 133.37 72.63 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -68.23 -40.65 8.2 Favored 'Trans proline' 0 N--CA 1.453 -0.912 0 C-N-CA 122.522 2.148 . . . . 0.0 111.658 178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.89 -44.09 94.05 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.037 -173.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.54 -31.35 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -178.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.95 -46.67 56.63 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.763 -0.16 . . . . 0.0 111.045 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.3 ptp -71.43 -25.19 62.21 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 117.992 0.36 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 87.1 mmm -74.29 -32.13 62.77 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.071 0.149 . . . . 0.0 110.849 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.3 mt -75.52 -31.32 60.09 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -69.63 -32.81 71.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.288 -0.258 . . . . 0.0 110.505 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -73.71 -40.37 63.65 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.862 0.363 . . . . 0.0 110.603 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -69.39 -28.0 65.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.96 -39.1 63.97 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 122.148 -0.345 . . . . 0.0 110.196 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.28 -35.61 76.24 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.542 -0.099 . . . . 0.0 111.181 -176.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.24 -23.76 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.086 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.17 13.5 5.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.425 0.29 . . . . 0.0 110.459 173.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 59.79 23.02 11.93 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 -176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -97.58 -177.93 3.96 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.109 0.563 . . . . 0.0 109.624 176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 6.3 m -130.05 112.23 17.15 Favored Pre-proline 0 C--O 1.232 0.17 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 64.0 Cg_endo -74.87 94.42 0.95 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.953 2.435 . . . . 0.0 108.727 170.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.0 m -75.09 -3.6 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -174.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.55 168.43 23.43 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 8.1 m -142.95 136.78 28.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.53 0.732 . . . . 0.0 111.04 176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 m -138.24 159.59 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 122.371 0.268 . . . . 0.0 111.166 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -123.28 4.92 9.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 p -130.91 149.57 52.48 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.257 0.623 . . . . 0.0 111.419 173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -74.83 -24.83 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.12 -26.77 64.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -33.09 34.84 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.2 70.1 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.27 0.535 . . . . 0.0 110.458 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.9 mt -71.72 -34.95 70.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.28 -23.07 59.05 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 119.81 -0.138 . . . . 0.0 111.157 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 74.1 mmt-85 -88.98 -39.89 13.4 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.1 p -72.57 -29.69 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.557 -0.457 . . . . 0.0 112.174 -178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -80.94 -15.61 55.8 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -113.92 -19.2 11.55 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -93.72 -14.85 51.75 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 119.372 -0.682 . . . . 0.0 113.152 -172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 59.32 34.44 80.39 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 mt -66.58 147.12 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.035 0.934 . . . . 0.0 111.35 -169.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -81.37 -31.62 33.25 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.587 0.355 . . . . 0.0 110.985 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.43 171.45 17.11 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.042 0.537 . . . . 0.0 109.818 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.3 164.9 34.58 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.014 0.435 . . . . 0.0 112.004 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 15.5 mt -123.72 143.45 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.8 tp -142.87 128.65 19.34 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -170.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -81.06 147.23 30.24 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.65 -32.28 53.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 O-C-N 122.334 -0.229 . . . . 0.0 110.715 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.45 123.86 18.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.3 mp -85.7 -172.53 4.16 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 45.7 ttt85 -54.99 140.37 37.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.378 -177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.41 -3.58 86.92 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -174.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.51 4.68 87.59 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 117.269 0.534 . . . . 0.0 112.735 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -73.16 142.6 47.41 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.818 . . . . 0.0 110.613 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -71.6 158.55 36.01 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.3 m -148.35 115.7 6.21 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.465 0.174 . . . . 0.0 111.223 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -134.68 2.2 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 169.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.9 Cg_endo -69.06 -25.32 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.725 1.617 . . . . 0.0 110.557 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.5 m -87.43 -28.95 5.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 CA-C-N 117.511 0.141 . . . . 0.0 111.245 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.16 -30.54 65.1 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -76.71 -28.49 55.86 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.141 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.08 -29.87 55.18 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -30.61 67.05 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.45 58.15 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.49 -36.72 57.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.59 0.356 . . . . 0.0 110.289 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 59.7 mtt-85 -81.8 -1.18 46.43 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.587 0.755 . . . . 0.0 111.561 177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.5 t0 53.15 52.57 13.43 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.061 0.544 . . . . 0.0 111.23 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.1 pt -128.24 149.74 72.11 Favored Pre-proline 0 CA--C 1.529 0.158 0 C-N-CA 122.859 0.464 . . . . 0.0 110.085 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 19.0 Cg_exo -65.6 150.41 86.53 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.573 2.848 . . . . 0.0 111.774 -176.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.04 142.96 29.11 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.0 t -119.41 147.61 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -100.67 158.44 15.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.3 138.82 54.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.5 p -140.73 176.97 8.36 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.179 0.514 . . . . 0.0 109.991 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -171.94 -146.9 5.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.07 138.21 23.21 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.8 m 60.14 12.71 3.4 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -141.41 12.21 2.14 Favored 'General case' 0 N--CA 1.46 0.051 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -76.12 8.48 3.22 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 79.0 p -81.28 38.07 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.075 0.95 . . . . 0.0 111.647 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 p -55.25 143.39 8.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -70.23 150.64 46.22 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -172.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.0 m -66.18 -12.77 58.07 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 122.555 0.342 . . . . 0.0 110.578 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -64.71 -15.73 61.89 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.475 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -134.51 6.29 3.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.266 0.226 . . . . 0.0 110.904 -175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 45.2 mmm-85 -69.1 -11.23 60.6 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-N 117.961 0.346 . . . . 0.0 111.724 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -79.2 -10.48 59.83 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.36 157.15 36.32 Favored Pre-proline 0 N--CA 1.455 -0.215 0 C-N-CA 123.782 0.833 . . . . 0.0 109.197 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.99 167.72 26.62 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 123.184 2.59 . . . . 0.0 110.531 -177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 p -146.47 128.88 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.6 mt -86.15 153.19 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 169.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -139.15 -115.7 0.14 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 165.67 1.59 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.7 0.8 . . . . 0.0 110.317 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.96 145.64 10.06 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.901 2.401 . . . . 0.0 111.79 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -133.75 152.97 52.02 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -169.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.0 p -83.52 176.61 8.92 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.5 tpt -60.41 -29.85 69.24 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -82.89 -21.58 34.22 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.78 -37.22 51.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.06 -28.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 117.189 0.495 . . . . 0.0 110.79 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.62 -26.7 62.68 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -70.74 -39.29 73.39 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.97 0.508 . . . . 0.0 110.167 178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.08 -43.06 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -68.31 -24.83 64.88 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -81.67 -36.26 28.97 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.65 63.12 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.852 0.461 . . . . 0.0 111.386 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 74.1 mt -64.78 -23.59 67.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.835 0.289 . . . . 0.0 110.39 174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 117' ' ' LEU . 3.3 mm? -109.8 -36.66 5.85 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 122.707 0.403 . . . . 0.0 110.02 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.8 t . . . . . 0 C--O 1.25 1.081 0 CA-C-O 117.186 -1.387 . . . . 0.0 110.482 -175.342 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mtp . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t 61.0 164.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.926 0.89 . . . . 0.0 112.252 -176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -86.03 2.04 47.96 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.069 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -156.49 123.55 5.27 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.714 0.406 . . . . 0.0 110.17 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -152.29 -44.24 0.1 Allowed 'General case' 0 C--O 1.23 0.073 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -77.6 115.24 17.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.318 0.508 . . . . 0.0 109.804 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.1 mt -129.87 136.76 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 122.683 0.393 . . . . 0.0 110.459 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tp -102.76 151.78 22.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 174.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.8 mt -120.94 143.03 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.5 t -138.09 99.83 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -164.96 172.67 12.49 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.042 0.537 . . . . 0.0 109.705 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -117.09 -10.75 10.82 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -80.57 129.94 66.67 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.649 -0.657 . . . . 0.0 109.69 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -72.15 -36.6 5.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.859 2.372 . . . . 0.0 111.625 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.07 -43.08 99.56 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 26.2 mm -75.3 -31.37 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.4 -37.75 77.65 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 8.1 mtm -66.94 -35.09 79.2 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.306 0.242 . . . . 0.0 110.811 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 93.7 mmm -78.24 -33.96 49.44 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.088 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 -28.55 59.17 Favored 'General case' 0 N--CA 1.46 0.07 0 O-C-N 122.231 -0.293 . . . . 0.0 110.603 179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -68.35 -36.51 79.34 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -73.63 -43.22 60.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.565 0.221 . . . . 0.0 111.14 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -70.6 -30.79 67.56 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 -175.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.8 mt -74.77 -37.44 62.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -70.52 -36.83 73.97 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.503 -0.123 . . . . 0.0 111.254 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -75.82 -23.92 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.5 mt -85.48 14.5 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.709 0.404 . . . . 0.0 110.529 174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 59.47 22.9 11.46 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -94.23 -174.96 3.52 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 1.3 m -133.27 110.85 12.78 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 68.1 Cg_endo -75.42 90.42 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 123.217 2.611 . . . . 0.0 108.679 170.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.3 m -77.71 0.83 2.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.81 164.84 16.45 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.123 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 88.6 m -145.44 141.12 28.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.527 0.731 . . . . 0.0 109.607 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.1 m -138.16 157.19 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 C-N-CA 122.56 0.344 . . . . 0.0 110.873 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -113.77 2.37 15.14 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.9 p -131.9 150.95 52.0 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.223 0.609 . . . . 0.0 111.79 174.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.55 -24.77 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -174.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.4 -28.94 67.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.46 -31.92 44.21 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.07 -36.45 69.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 117.066 0.433 . . . . 0.0 110.462 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.32 -31.06 69.27 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.42 -25.38 46.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.058 0.143 . . . . 0.0 111.236 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -87.09 -35.22 18.82 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -76.46 -23.01 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 CA-C-N 118.142 0.428 . . . . 0.0 111.888 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.33 -20.41 60.12 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.471 0.308 . . . . 0.0 110.487 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -68.57 -19.26 64.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.1 -171.42 45.85 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.31 -6.66 42.66 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.324 0.488 . . . . 0.0 111.958 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.1 mt -90.29 142.22 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 CA-C-N 117.353 0.577 . . . . 0.0 109.927 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -106.82 -17.97 14.06 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.43 169.23 19.2 Favored 'General case' 0 C--N 1.338 0.08 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 175.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.12 168.68 22.55 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.065 -0.397 . . . . 0.0 111.402 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 13.8 mt -126.3 143.33 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 123.414 0.686 . . . . 0.0 109.159 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.19 123.02 16.48 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.135 0.421 . . . . 0.0 112.135 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -78.58 142.16 37.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.22 -27.46 43.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -133.59 121.02 21.47 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mp -88.5 -169.1 2.42 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 50.4 ttt85 -55.89 140.08 43.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.055 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.05 85.59 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -174.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.25 7.03 86.83 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 117.462 0.631 . . . . 0.0 112.281 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -74.13 142.64 45.54 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.658 0.729 . . . . 0.0 111.019 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -75.6 151.5 37.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 123.901 0.88 . . . . 0.0 110.921 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 80.1 p -154.92 134.06 12.38 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.26 0.224 . . . . 0.0 110.623 178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.7 p -138.99 5.0 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 171.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.6 Cg_endo -67.35 -25.82 41.91 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.866 1.71 . . . . 0.0 110.923 -170.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 m -85.73 -28.14 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.205 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.04 -30.28 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.62 -29.8 56.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.69 -32.28 60.05 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.68 -33.29 73.72 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.79 -27.85 61.35 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.757 -0.09 . . . . 0.0 110.757 177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.5 -32.23 32.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.125 0.17 . . . . 0.0 110.633 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 -85.29 2.54 43.6 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.709 0.804 . . . . 0.0 111.348 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.3 t0 54.57 47.2 23.19 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.636 0.774 . . . . 0.0 111.433 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -126.74 141.6 40.85 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 122.848 0.459 . . . . 0.0 109.984 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.05 155.09 70.2 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.143 2.562 . . . . 0.0 111.712 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -144.52 142.79 30.48 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.73 152.84 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -105.58 154.9 19.76 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 170.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.64 140.94 48.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 174.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 58.5 p -141.63 177.3 8.24 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -151.23 -156.76 7.54 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -71.97 -11.16 74.05 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.106 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -143.86 -14.0 0.64 Allowed 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 117.534 0.667 . . . . 0.0 111.246 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.26 5.63 29.56 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -78.59 12.58 1.97 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 91.9 p -79.18 33.12 0.23 Allowed 'General case' 0 C--O 1.234 0.245 0 C-N-CA 123.69 0.796 . . . . 0.0 111.221 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 8.3 p -58.82 143.49 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.825 0.45 . . . . 0.0 110.103 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -76.17 150.84 37.07 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -174.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.3 p -64.65 -12.69 48.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.719 0.408 . . . . 0.0 110.505 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -65.12 -15.73 62.72 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.855 0.862 . . . . 0.0 111.021 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -133.15 3.38 3.68 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -174.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -70.69 -7.88 47.94 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.172 0.442 . . . . 0.0 111.752 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.9 p30 -80.7 -11.81 59.57 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 160.19 27.01 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.995 0.918 . . . . 0.0 109.415 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.76 166.0 31.18 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.949 2.433 . . . . 0.0 110.202 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.19 129.72 7.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.257 0.551 . . . . 0.0 110.311 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.1 mt -90.2 152.14 21.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -139.62 -116.51 0.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -173.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.85 165.28 1.79 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 123.838 0.855 . . . . 0.0 110.3 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -47.96 141.73 16.53 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.642 2.228 . . . . 0.0 111.586 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.1 152.48 49.5 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -169.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.1 p -83.49 175.95 9.42 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.486 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 4.7 tpt -61.51 -29.4 69.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -83.22 -20.81 33.89 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.54 -38.73 43.45 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.0 m -77.13 -29.15 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 117.43 0.615 . . . . 0.0 110.564 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.01 -25.84 62.86 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -73.19 -39.5 65.54 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 122.551 0.34 . . . . 0.0 110.537 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.6 -39.14 64.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.406 0.283 . . . . 0.0 111.088 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.79 -21.69 59.16 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.379 -0.201 . . . . 0.0 110.745 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.71 -33.08 47.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 176.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.71 -10.03 59.1 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.643 0.377 . . . . 0.0 110.608 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 42.4 tp -72.36 -23.53 61.15 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.46 -4.85 57.79 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.471 0.308 . . . . 0.0 111.547 -176.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.386 -1.292 . . . . 0.0 112.223 -178.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttm . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -74.43 171.53 13.57 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 122.545 0.338 . . . . 0.0 110.717 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.4 5.72 8.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.865 0.466 . . . . 0.0 111.919 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 30.2 tp -150.96 98.01 2.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.938 0.335 . . . . 0.0 110.754 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.1 p -141.13 -33.03 0.53 Allowed 'General case' 0 N--CA 1.458 -0.052 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -80.92 108.7 14.82 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.2 mt -130.06 137.89 55.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 120.496 0.189 . . . . 0.0 111.464 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 tp -102.95 153.06 20.6 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.823 0.449 . . . . 0.0 109.869 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 41.9 mt -124.86 143.26 39.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 t -134.09 107.84 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -151.36 166.54 30.7 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.392 0.677 . . . . 0.0 110.288 -172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -137.8 -3.88 1.81 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 81.5 tt0 -88.59 134.4 34.2 Favored Pre-proline 0 N--CA 1.455 -0.218 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 173.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' GLU . 39.0 Cg_exo -60.49 -42.08 43.45 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.401 2.067 . . . . 0.0 111.865 -177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.1 mt -69.15 -51.43 38.27 Favored 'General case' 0 C--O 1.227 -0.117 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 10.6 mm -68.77 -23.15 27.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 109.9 -173.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.59 -44.91 20.15 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 122.297 -0.252 . . . . 0.0 110.642 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 23.1 ptp -71.49 -26.17 62.58 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.124 0.42 . . . . 0.0 110.549 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 94.0 mtp -72.26 -39.35 68.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.0 mt -72.08 -28.36 63.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.44 0.109 . . . . 0.0 110.815 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.72 -38.16 80.0 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.262 -0.274 . . . . 0.0 110.49 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -73.63 -40.0 64.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.732 0.301 . . . . 0.0 111.234 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -74.48 -28.73 61.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.0 mt -77.42 -36.82 52.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.595 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -77.79 -24.91 48.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.18 -175.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.36 -25.45 11.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-N 118.115 0.416 . . . . 0.0 111.893 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.9 mt -81.89 12.12 4.36 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.709 0.404 . . . . 0.0 110.836 174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 57.28 22.55 7.82 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.16 -179.55 5.29 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.08 0.552 . . . . 0.0 109.625 174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 3.5 m -127.8 105.9 20.63 Favored Pre-proline 0 N--CA 1.453 -0.276 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -174.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 30' ' ' THR . 39.4 Cg_endo -71.69 98.84 0.9 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.764 2.31 . . . . 0.0 108.768 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.9 m -81.25 -0.44 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 160.8 163.84 14.64 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.03 174.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 m -143.42 134.59 25.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.383 0.673 . . . . 0.0 110.145 174.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 m -134.93 162.35 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 C-N-CA 122.314 0.246 . . . . 0.0 111.412 -176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.6 p30 -123.7 5.72 8.83 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -176.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 p -136.95 155.23 49.99 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.569 0.748 . . . . 0.0 111.803 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 m -71.44 -24.89 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.84 77.01 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.83 -32.71 35.87 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.559 -1.016 . . . . 0.0 110.559 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.81 -37.23 73.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 117.232 0.516 . . . . 0.0 110.734 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 77.9 mt -72.56 -31.43 65.24 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.06 -30.23 60.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 119.85 -0.119 . . . . 0.0 111.157 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -86.03 -34.38 20.77 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 p -76.18 -23.78 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 118.474 0.579 . . . . 0.0 112.059 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tp10 -74.5 -17.62 60.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.487 0.315 . . . . 0.0 110.986 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -65.32 -25.47 67.63 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.92 -177.2 35.34 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.42 61.66 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 77.6 mt -85.16 142.86 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.224 0.609 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.42 -22.66 15.93 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 122.473 0.309 . . . . 0.0 111.699 -175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.87 169.97 9.44 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.859 0.463 . . . . 0.0 110.094 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.22 166.16 27.85 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.608 0.242 . . . . 0.0 110.934 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 20.6 mt -129.68 143.62 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.02 127.31 17.65 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -171.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -80.87 148.79 29.76 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 174.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.23 -26.57 39.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 C-N-CA 122.88 0.472 . . . . 0.0 110.615 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -143.1 143.94 32.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.89 0.376 . . . . 0.0 110.946 177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.6 mp -108.21 -170.78 1.74 Allowed 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -50.04 139.51 13.95 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 120.811 0.339 . . . . 0.0 111.039 -178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 89.28 -7.01 83.0 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -173.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.94 1.43 62.66 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 123.646 0.641 . . . . 0.0 112.397 176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -69.25 144.9 53.52 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.873 0.837 . . . . 0.0 109.9 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -65.11 157.73 27.79 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -140.08 110.48 6.65 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.687 0.279 . . . . 0.0 111.449 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 1.4 p -133.61 9.37 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 169.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 66' ' ' THR . 57.2 Cg_endo -69.6 -24.34 30.53 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 120.8 1.321 . . . . 0.0 110.368 -175.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 72' ' ' LEU . 2.7 m -89.76 -39.92 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.4 -26.9 68.95 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 118.265 0.484 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -74.86 -27.99 60.48 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.13 -40.23 31.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.366 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 68' ' ' VAL . 4.6 mm? -61.3 -39.68 91.35 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -32.19 66.71 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.475 -0.141 . . . . 0.0 111.24 -179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -25.03 38.82 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 122.18 -0.325 . . . . 0.0 111.166 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 58.9 mtp85 -90.64 5.29 48.63 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.039 0.535 . . . . 0.0 110.877 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.1 t0 58.99 24.54 12.77 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.38 1.072 . . . . 0.0 111.562 -178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.6 mt -94.48 133.26 27.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.1 153.8 61.93 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.65 2.9 . . . . 0.0 112.049 176.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -150.51 146.9 26.89 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.47 146.97 22.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.122 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -95.93 156.97 16.11 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 170.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.98 136.41 52.22 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.8 p -145.97 178.59 8.08 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.624 1.17 . . . . 0.0 110.851 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.12 -161.06 8.56 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.63 -9.37 65.13 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.836 -0.424 . . . . 0.0 112.397 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 73.4 m -144.03 -0.58 1.01 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 117.489 0.645 . . . . 0.0 111.745 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -102.5 14.6 31.52 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -75.24 24.53 0.1 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.9 m -75.34 23.85 0.11 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.314 0.646 . . . . 0.0 111.97 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 p -64.01 145.15 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -72.66 146.01 46.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 40.5 t -65.72 -14.66 61.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.294 0.238 . . . . 0.0 110.686 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 50.5 tpt85 -64.59 -12.9 50.21 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.163 0.585 . . . . 0.0 110.271 174.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -133.43 7.2 3.86 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.326 0.25 . . . . 0.0 111.418 -177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 47.0 mtt180 -73.48 -5.71 41.78 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 121.921 -0.487 . . . . 0.0 111.883 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -92.59 -9.9 39.42 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.345 0.258 . . . . 0.0 111.59 172.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -79.95 159.55 70.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.36 148.05 87.91 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.434 2.089 . . . . 0.0 108.618 171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 p -152.59 126.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.4 0.619 . . . . 0.0 110.571 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.9 mt -82.17 137.77 34.87 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -140.84 2.0 1.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -162.34 165.24 15.91 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -170.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 18.7 Cg_endo -58.2 96.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.652 2.235 . . . . 0.0 109.334 172.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -79.77 152.88 29.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.5 p -88.31 177.22 6.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.3 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.504 ' HE3' ' HA ' ' A' ' 106' ' ' MET . 3.9 tpt -61.86 -30.16 70.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -83.14 -22.46 33.3 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 178.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -75.05 -36.8 45.22 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.2 m -77.17 -29.42 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 117.479 0.64 . . . . 0.0 110.061 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.55 63.71 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -73.92 -40.54 63.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.67 0.388 . . . . 0.0 110.276 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -43.21 62.26 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.905 -0.134 . . . . 0.0 110.818 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 97.1 mt -69.23 -24.33 63.99 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.255 -0.178 . . . . 0.0 110.657 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.06 -24.84 43.29 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.38 -14.65 60.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.119 0.168 . . . . 0.0 110.676 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.9 mt -70.18 -10.47 58.94 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 122.25 -0.281 . . . . 0.0 111.569 174.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.44 -7.16 32.3 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.866 0.303 . . . . 0.0 111.376 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.772 -1.108 . . . . 0.0 112.547 -178.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ptp . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p 48.04 31.69 2.57 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.11 0.964 . . . . 0.0 112.169 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.5 6.2 9.12 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.546 0.339 . . . . 0.0 111.52 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.45 125.12 24.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.054 0.542 . . . . 0.0 110.189 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.46 -41.73 0.12 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -79.0 112.82 16.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.24 0.473 . . . . 0.0 110.517 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.4 mt -129.78 131.73 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.448 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.38 153.32 17.75 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.3 mt -126.25 142.45 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.09 99.79 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 122.385 0.274 . . . . 0.0 110.326 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -150.92 166.95 29.07 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.2 p30 -118.15 -4.63 10.97 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -96.97 133.0 24.78 Favored Pre-proline 0 CA--C 1.531 0.241 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -69.96 -40.38 5.08 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.478 2.119 . . . . 0.0 111.705 178.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.99 -42.42 99.84 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 122.144 0.177 . . . . 0.0 111.056 -172.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 mm -75.6 -31.07 22.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-N 117.986 0.357 . . . . 0.0 110.068 -178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.72 -41.2 68.82 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.528 -0.107 . . . . 0.0 110.804 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.1 ptp -73.94 -25.01 59.73 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.832 0.287 . . . . 0.0 110.404 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 83.9 mtp -69.22 -36.86 77.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 173.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.3 mt -74.74 -29.19 61.08 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 122.5 -0.125 . . . . 0.0 110.954 -178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -70.02 -31.21 68.75 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.898 0.317 . . . . 0.0 110.4 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -76.17 -42.4 46.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.714 0.292 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -70.44 -28.46 65.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.2 -37.61 63.84 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.5 tp10 -69.08 -35.64 76.73 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.49 -24.66 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 O-C-N 122.211 -0.306 . . . . 0.0 111.605 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.0 mt -83.53 13.19 4.73 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.745 0.418 . . . . 0.0 110.637 173.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 59.05 22.88 10.99 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -96.36 -176.02 3.52 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 m -135.17 117.35 12.5 Favored Pre-proline 0 N--CA 1.456 -0.143 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.89 88.62 1.21 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.187 2.591 . . . . 0.0 108.789 170.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -73.3 -5.31 6.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 161.13 165.44 17.91 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 122.001 -0.437 . . . . 0.0 112.131 175.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 m -142.89 140.45 31.21 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.672 0.789 . . . . 0.0 109.66 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 m -133.18 154.38 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 122.325 0.25 . . . . 0.0 111.239 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p30 -111.36 3.16 18.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 p -132.33 149.91 52.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.247 0.619 . . . . 0.0 111.609 174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.4 p -76.22 -24.5 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.58 -26.56 64.53 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.4 -29.46 44.56 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.274 -1.131 . . . . 0.0 110.274 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.64 60.84 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.062 0.431 . . . . 0.0 110.193 178.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.01 -33.02 71.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 175.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.0 -28.61 60.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.055 0.142 . . . . 0.0 110.754 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -77.21 -45.93 24.96 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.91 -23.18 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.759 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -74.91 -22.2 58.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.155 0.182 . . . . 0.0 110.91 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -73.4 -16.4 61.33 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.79 -170.22 51.65 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.81 -4.76 56.06 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 111.756 -0.538 . . . . 0.0 111.756 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 56.0 mt -99.33 140.14 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -109.3 -13.69 14.59 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 168.36 23.65 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.63 168.87 23.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.817 0.341 . . . . 0.0 111.54 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 14.6 mt -131.22 143.41 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.4 tp -140.19 127.78 21.59 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -172.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.49 153.46 26.82 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.08 -25.99 39.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 C-N-CA 122.792 0.437 . . . . 0.0 111.692 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.31 144.98 25.88 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.68 0.392 . . . . 0.0 111.031 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.2 mp -109.58 -168.14 1.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.014 0.926 . . . . 0.0 108.883 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 mtp180 -51.25 142.25 13.33 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.914 0.388 . . . . 0.0 111.073 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.52 -0.76 84.58 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -175.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.33 6.03 78.98 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 117.449 0.625 . . . . 0.0 111.799 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -70.49 135.81 48.91 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 117.536 0.668 . . . . 0.0 110.142 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.433 ' CD ' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -74.19 161.7 29.69 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 122.655 0.382 . . . . 0.0 110.404 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 65.5 p -156.53 130.92 8.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.701 0.286 . . . . 0.0 111.124 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.589 ' N ' ' CD ' ' A' ' 67' ' ' PRO . 2.5 p -139.67 5.89 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 169.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 66' ' ' THR . 59.7 Cg_endo -68.08 -27.21 36.12 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 121.571 1.514 . . . . 0.0 110.788 -170.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.64 -28.4 6.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.268 0 O-C-N 122.283 -0.26 . . . . 0.0 111.348 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.75 -30.14 63.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -76.16 -30.49 58.14 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.67 -33.03 60.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -33.18 73.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.26 -29.64 62.89 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.312 -0.243 . . . . 0.0 110.653 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.56 -31.39 36.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.48 0.312 . . . . 0.0 110.636 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 mtt-85 -86.22 2.77 45.81 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.519 0.728 . . . . 0.0 111.385 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.4 t0 54.74 47.2 23.0 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.379 0.672 . . . . 0.0 111.545 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 1.0 OUTLIER -126.53 144.43 49.57 Favored Pre-proline 0 CA--C 1.535 0.365 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.216 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' ILE . 23.0 Cg_exo -64.55 151.13 86.76 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.565 2.843 . . . . 0.0 112.15 -176.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -145.73 146.95 31.44 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -121.51 148.91 24.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -95.41 158.06 15.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 170.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -129.12 146.07 51.15 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.79 176.08 9.51 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.44 -164.71 10.48 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -79.62 7.55 53.54 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 119.566 -0.575 . . . . 0.0 113.279 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 87.6 p -145.23 9.17 1.24 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 117.963 0.881 . . . . 0.0 112.181 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -145.63 17.13 1.47 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 p30 -64.77 5.69 0.29 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 68.4 m -80.36 43.12 0.62 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.794 0.837 . . . . 0.0 110.976 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.51 145.14 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -62.54 148.82 44.76 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.357 0.663 . . . . 0.0 110.573 -169.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 91.9 p -65.96 -16.25 63.71 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 123.001 0.52 . . . . 0.0 110.64 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -68.19 -13.34 62.16 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.144 0.578 . . . . 0.0 110.653 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -133.57 9.4 3.97 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -66.68 -16.06 63.95 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 122.105 -0.372 . . . . 0.0 111.265 177.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -83.26 -16.11 47.6 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -86.54 158.44 54.35 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.815 0.446 . . . . 0.0 110.061 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.67 155.46 69.97 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 122.577 2.185 . . . . 0.0 109.774 174.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 p -151.46 130.18 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-O 121.088 0.471 . . . . 0.0 110.046 -177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.84 154.31 18.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.172 170.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.56 -122.82 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.231 -0.293 . . . . 0.0 110.774 -177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -51.38 165.14 0.43 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.407 0.683 . . . . 0.0 110.674 175.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 102' ' ' LYS . 85.8 Cg_exo -45.59 138.17 11.14 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.077 2.518 . . . . 0.0 111.777 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.85 151.96 49.03 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -170.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 p -78.56 171.52 15.0 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -31.73 71.02 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -81.23 -21.19 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 122.038 -0.414 . . . . 0.0 112.015 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.72 -40.11 53.85 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.3 m -76.31 -28.4 18.23 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.13 0 O-C-N 122.406 -0.467 . . . . 0.0 110.425 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.33 -25.89 62.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -70.52 -39.44 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.635 0.374 . . . . 0.0 110.051 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.24 62.89 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 122.222 0.209 . . . . 0.0 111.049 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.15 -23.64 63.03 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 110.553 -0.165 . . . . 0.0 110.553 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -80.24 -25.77 39.39 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 110.379 -0.23 . . . . 0.0 110.379 175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.46 -14.53 60.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 122.235 0.214 . . . . 0.0 110.94 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 98.1 mt -68.23 -11.28 59.06 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 122.074 -0.391 . . . . 0.0 111.183 175.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.26 -8.51 32.66 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.814 0.279 . . . . 0.0 111.538 -176.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.251 1.167 0 CA-C-O 116.981 -1.485 . . . . 0.0 112.568 -178.07 . . . . . . . . 0 0 . 1 stop_ save_